ࡱ>  )bjbj|| 7}g}gh fffffzzz8|.Tz']]]'''''''$*h-\?'Qf]]]]]?'ff'9&9&9&]ff'9&]'9&9&9&R^ 9&''0'9&-$-9&-f9&]]9&]]]]]?'?'{%]]]']]]]-]]]]]]]]] X ,: 4.71a Schedule of ratingsmusculoskeletal system. Acute, Subacute, or Chronic Diseases Rating 5000 Osteomyelitis, acute, subacute, or chronic: Of the pelvis, vertebrae, or extending into major joints, or with multiple localization or with long history of intractability and debility, anemia, amyloid liver changes, or other continuous constitutional symptoms 100 Frequent episodes, with constitutional symptoms 60 With definite involucrum or sequestrum, with or without discharging sinus 30 With discharging sinus or other evidence of active infection within the past 5 years 20 Inactive, following repeated episodes, without evidence of active infection in past 5 years 10 Note (1): A rating of 10 percent, as an exception to the amputation rule, is to be assigned in any case of active osteomyelitis where the amputation rating for the affected part is no percent. This 10 percent rating and the other partial ratings of 30 percent or less are to be combined with ratings for ankylosis, limited motion, nonunion or malunion, shortening, etc., subject, of course, to the amputation rule. The 60 percent rating, as it is based on constitutional symptoms, is not subject to the amputation rule. A rating for osteomyelitis will not be applied following cure by removal or radical resection of the affected bone. Note (2): The 20 percent rating on the basis of activity within the past 5 years is not assignable following the initial infection of active osteomyelitis with no subsequent reactivation. The prerequisite for this historical rating is an established recurrent osteomyelitis. To qualify for the 10 percent rating, 2 or more episodes following the initial infection are required. This 20 percent rating or the 10 percent rating, when applicable, will be assigned once only to cover disability at all sites of previously active infection with a future ending date in the case of the 20 percent rating. 5001 Bones and joints, tuberculosis of, active or inactive: Active 100 Inactive: See 4.88c and 4.89 5002 Multi-joint arthritis (except post-traumatic and gout), 2 or more joints, as an active process: With constitutional manifestations associated with active joint involvement, totally incapacitating 100 Less than criteria for 100% but with weight loss and anemia productive of severe impairment of health or severely incapacitating exacerbations occurring 4 or more times a year or a lesser number over prolonged periods 60 Symptom combinations productive of definite impairment of health objectively supported by examination findings or incapacitating exacerbations occurring 3 or more times a year 40 One or two exacerbations a year in a well-established diagnosis 20 Note (1): Examples of conditions rated using this diagnostic code include, but are not limited to, rheumatoid arthritis, psoriatic arthritis, and spondyloarthropathies. Note (2): For chronic residuals, rate under diagnostic code 5003. Note (3): The ratings for the active process will not be combined with the residual ratings for limitation of motion, ankylosis, or diagnostic code 5003. Instead, assign the higher evaluation. 5003 Degenerative arthritis, other than post-traumatic: Degenerative arthritis established by X-ray findings will be rated on the basis of limitation of motion under the appropriate diagnostic codes for the specific joint or joints involved (DC 5200 etc.). When however, the limitation of motion of the specific joint or joints involved is noncompensable under the appropriate diagnostic codes, a rating of 10 pct is for application for each such major joint or group of minor joints affected by limitation of motion, to be combined, not added under diagnostic code 5003. Limitation of motion must be objectively confirmed by findings such as swelling, muscle spasm, or satisfactory evidence of painful motion. In the absence of limitation of motion, rate as below With X-ray evidence of involvement of 2 or more major joints or 2 or more minor joint groups with occasional incapacitating exacerbations 20 With X-ray evidence of involvement of 2 or more major joints or 2 or more minor joint groups 10 Note (1): The 20 pct and 10 pct ratings based on X-ray findings, above, will not be combined with ratings based on limitation of motion. Note (2): The 20 pct and 10 pct ratings based on X-ray findings, above, will not be utilized in rating conditions listed under diagnostic codes 5013 to 5024, inclusive. 5004 Arthritis, gonorrheal. 5005 Arthritis, pneumococcic. 5006 Arthritis, typhoid. 5007 Arthritis, syphilitic. 5008 Arthritis, streptococcic. 5009 Other specified forms of arthropathy (excluding gout). Note (1): Other specified forms of arthropathy include, but are not limited to, Charcot neuropathic, hypertrophic, crystalline, and other autoimmune arthropathies. Note (2): With the types of arthritis, diagnostic codes 5004 through 5009, rate the acute phase under diagnostic code 5002; rate any chronic residuals under diagnostic code 5003. 5010 Post-traumatic arthritis: Rate as limitation of motion, dislocation, or other specified instability under the affected joint. If there are 2 or more joints affected, each rating shall be combined in accordance with 4.25. 5011 Decompression illness: Rate manifestations under the appropriate diagnostic code within the affected body system, such as arthritis for musculoskeletal residuals; auditory system for vestibular residuals; respiratory system for pulmonary barotrauma residuals; and neurologic system for cerebrovascular accident residuals. 5012 Bones, neoplasm, malignant, primary or secondary 100 Note: The 100 percent rating will be continued for 1 year following the cessation of surgical, X-ray, antineoplastic chemotherapy or other prescribed therapeutic procedure. If there has been no local recurrence or metastases, rate based on residuals. 5013 Osteoporosis, residuals of. 5014 Osteomalacia, residuals of. 5015 Bones, neoplasm, benign. 5016 Osteitis deformans. 5017 Gout. 5018 [Removed] 5019 Bursitis. 5020 [Removed] 5021 Myositis. 5022 [Removed] 5023 Heterotopic ossification. 5024 Tenosynovitis, tendinitis, tendinosis or tendinopathy. Note to DCs 5013 through 5024: Evaluate the diseases under diagnostic codes 5013 through 5024 as degenerative arthritis, based on limitation of motion of affected parts. 5025 Fibromyalgia (fibrositis, primary fibromyalgia syndrome) With widespread musculoskeletal pain and tender points, with or without associated fatigue, sleep disturbance, stiffness, paresthesias, headache, irritable bowel symptoms, depression, anxiety, or Raynauds-like symptoms: That are constant, or nearly so, and refractory to therapy 40 That are episodic, with exacerbations often precipitated by environmental or emotional stress or by overexertion, but that are present more than one-third of the time 20 That require continuous medication for control 10 Note: Widespread pain means pain in both the left and right sides of the body, that is both above and below the waist, and that affects both the axial skeleton (i.e., cervical spine, anterior chest, thoracic spine, or low back) and the extremities. Prosthetic Implants and Resurfacing Note (1): When an evaluation is assigned for joint resurfacing or the prosthetic replacement of a joint under diagnostic codes 5051-5056, an additional rating under 4.71a may not also be assigned for that joint, unless otherwise directed. Note (2): Only evaluate a revision procedure in the same manner as the original procedure under diagnostic codes 5051-5056 if all the original components are replaced. Note (3): The term prosthetic replacement in diagnostic codes 5051- 5053 and 5055-5056 means a total replacement of the named joint. However, in DC 5054, prosthetic replacement means a total replacement of the head of the femur or of the acetabulum. Note (4): The 100 percent rating for 1 year following implantation of prosthesis will commence after initial grant of the 1-month total rating assigned under 4.30 following hospital discharge. Note (5): The 100 percent rating for 4 months following implantation of prosthesis or resurfacing under DCs 5054 and 5055 will commence after initial grant of the 1-month total rating assigned under 4.30 following hospital discharge. Note (6): Special monthly compensation is assignable during the 100 percent rating period the earliest date permanent use of crutches is established. Rating Major Minor 5051 Shoulder replacement (prosthesis). Prosthetic replacement of the shoulder joint: For 1 year following implantation of prosthesis 100 100 With chronic residuals consisting of severe, painful motion or weakness in the affected extremity 60 50 With intermediate degrees of residual weakness, pain or limitation of motion, rate by analogy to diagnostic codes 5200 and 5203. Minimum rating 30 20 5052 Elbow replacement (prosthesis). Prosthetic replacement of the elbow joint: For 1 year following implantation of prosthesis 100 100 With chronic residuals consisting of severe painful motion or weakness in the affected extremity 50 40 With intermediate degrees of residual weakness, pain or limitation of motion rate by analogy to diagnostic codes 5205 through 5208. Minimum evaluation 30 20 5053 Wrist replacement (prosthesis). Prosthetic replacement of wrist joint: For 1 year following implantation of prosthesis 100 100 With chronic residuals consisting of severe, painful motion or weakness in the affected extremity 40 30 With intermediate degrees of residual weakness, pain or limitation of motion, rate by analogy to diagnostic code 5214. Minimum rating 20 20 5054 Hip, resurfacing or replacement (prosthesis): For 4 months following implantation of prosthesis or resurfacing 100 Prosthetic replacement of the head of the femur or of the acetabulum: Following implantation of prosthesis with painful motion or weakness such as to require the use of crutches 901 Markedly severe residual weakness, pain or limitation of motion following implantation of prosthesis 70 Moderately severe residuals of weakness, pain or limitation of motion 50 Minimum evaluation, total replacement only 30 Note: At the conclusion of the 100 percent evaluation period, evaluate resurfacing under diagnostic codes 5250 through 5255; there is no minimum evaluation for resurfacing. 5055 Knee, resurfacing or replacement (prosthesis): For 4 months following implantation of prosthesis or resurfacing 100 Prosthetic replacement of knee joint: With chronic residuals consisting of severe painful motion or weakness in the affected extremity 60 With intermediate degrees of residual weakness, pain or limitation of motion rate by analogy to diagnostic codes 5256, 5261, or 5262. Minimum evaluation, total replacement only 30 Note: At the conclusion of the 100 percent evaluation period, evaluate resurfacing under diagnostic codes 5256 through 5262; there is no minimum evaluation for resurfacing. 5056 Ankle replacement (prosthesis). Prosthetic replacement of ankle joint: For 1 year following implantation of prosthesis 100 With chronic residuals consisting of severe painful motion or weakness 40 With intermediate degrees of residual weakness, pain or limitation of motion rate by analogy to 5270 or 5271. Minimum rating 20 combinations of disabilities 5104 Anatomical loss of one hand and loss of use of one foot 1001 5105 Anatomical loss of one foot and loss of use of one hand 1001 5106 Anatomical loss of both hands 1001 5107 Anatomical loss of both feet 1001 5108 Anatomical loss of one hand and one foot 1001 5109 Loss of use of both hands 1001 5110 Loss of use of both feet 1001 5111 Loss of use of one hand and one foot 1001 1Also entitled to special monthly compensation. Amputations: Upper Extremity Rating Major Minor Arm, amputation of: 5120 Complete amputation, upper extremity: Forequarter amputation (involving complete removal of the humerus along with any portion of the scapula, clavicle, and/or ribs) 1001 1001 Disarticulation (involving complete removal of the humerus only) 901 901 5121 Above insertion of deltoid 901 801 5122 Below insertion of deltoid 801 701 Forearm, amputation of: 5123 Above insertion of pronator teres 801 701 5124 Below insertion of pronator teres 701 601 5125 Hand, loss of use of 701 601 multiple finger amputations 5126 Five digits of one hand, amputation 701 601 Four digits of one hand, amputation of: 5127 Thumb, index, long and ring 701 601 5128 Thumb, index, long and little 701 601 5129 Thumb, index, ring and little 701 601 5130 Thumb, long, ring and little 701 601 5131 Index, long, ring and little 60 50 Three digits of one hand, amputation of: 5132 Thumb, index and long 60 50 5133 Thumb, index and ring 60 50 5134 Thumb, index and little 60 50 5135 Thumb, long and ring 60 50 5136 Thumb, long and little 60 50 5137 Thumb, ring and little 60 50 5138 Index, long and ring 50 40 5139 Index, long and little 50 40 5140 Index, ring and little 50 40 5141 Long, ring and little 40 30 Two digits of one hand, amputation of: 5142 Thumb and index 50 40 5143 Thumb and long 50 40 5144 Thumb and ring 50 40 5145 Thumb and little 50 40 5146 Index and long 40 30 5147 Index and ring 40 30 5148 Index and little 40 30 5149 Long and ring 30 20 5150 Long and little 30 20 5151 Ring and little 30 20 (a) The ratings for multiple finger amputations apply to amputations at the proximal interphalangeal joints or through proximal phalanges. (b) Amputation through long phalanges will be rated as prescribed for unfavorable ankylosis of the fingers. (c) Amputations at distal joints, or through distal phalanges, other than negligible losses, will be rated as prescribed for favorable ankylosis of the fingers. (d) Amputation or resection of metacarpal bones (more than one-half the bone lost) in multiple fingers injuries will require a rating of 10 percent added to (not combined with) the ratings, multiple finger amputations, subject to the amputation rule applied to the forearm. (e) Combinations of finger amputations at various levels, or finger amputations with ankylosis or limitation of motion of the fingers will be rated on the basis of the grade of disability; i.e., amputation, unfavorable ankylosis, most representative of the levels or combinations. With an even number of fingers involved, and adjacent grades of disability, select the higher of the two grades. (f) Loss of use of the hand will be held to exist when no effective function remains other than that which would be equally well served by an amputation stump with a suitable prosthetic appliance. single finger amputations 5152 Thumb, amputation of: With metacarpal resection 40 30 At metacarpophalangeal joint or through proximal phalanx 30 20 At distal joint or through distal phalanx 20 20 5153 Index finger, amputation of With metacarpal resection (more than one-half the bone lost) 30 20 5153 Index finger, amputation of (cont.) Without metacarpal resection, at proximal interphalangeal joint or proximal thereto 20 20 Through long phalanx or at distal joint 10 10 5154 Long finger, amputation of: With metacarpal resection (more than one-half the bone lost) 20 20 Without metacarpal resection, at proximal interphalangeal joint or proximal thereto 10 10 5155 Ring finger, amputation of: With metacarpal resection (more than one-half the bone lost) 20 20 Without metacarpal resection, at proximal interphalangeal joint or proximal thereto 10 10 5156 Little finger, amputation of: With metacarpal resection (more than one-half the bone lost) 20 20 Without metacarpal resection, at proximal interphalangeal joint or proximal thereto 10 10 Note: The single finger amputation ratings are the only applicable ratings for amputations of whole or part of single fingers. 1Entitled to special monthly compensation. Amputations: Lower Extremity Thigh, amputation of: 5160 Complete amputation, lower extremity: Trans-pelvic amputation (involving complete removal of the femur and intrinsic pelvic musculature along with any portion of the pelvic bones) 1002 Disarticulation (involving complete removal of the femur and intrinsic pelvic musculature only) 902 Note: Separately evaluate residuals involving other body systems (e.g., bowel impairment, bladder impairment) under the appropriate diagnostic code 5161 Upper third, one-third of the distance from perineum to knee joint measured from perineum 802 5162 Middle or lower thirds 602 Leg, amputation of: 5163 With defective stump, thigh, amputation recommended 602 5164 Amputation not improvable by prosthesis controlled by natural knee action 602 5165 At a lower level, permitting prosthesis 402 5166 Forefoot, amputation proximal to metatarsal bones (more than one-half of metatarsal loss) 402 5167 Foot, loss of use of 402 5170 Toes, all, amputation of, without metatarsal loss 30 or transmetatarsal, amputation of, with up to half of metatarsal loss 30 5171 Toe, great, amputation of: With removal of metatarsal head 30 Without metatarsal involvement 10 5172 Toes, other than great, amputation of, with removal of metatarsal head: One or two 20 Without metatarsal involvement 0 5173 Toes, three or four, amputation of, without metatarsal involvement: Including great toe 20 Not including great toe 10 2Also entitled to special monthly compensation. The Shoulder and Arm Rating Major Minor 5200 Scapulohumeral articulation, ankylosis of: Note: The scapula and humerus move as one piece. Unfavorable, abduction limited to 25 from side 50 40 Intermediate between favorable and unfavorable 40 30 Favorable, abduction to 60, can reach mouth and head 30 20 5201 Arm, limitation of motion of: Flexion and/or abduction limited to 25 from side 40 30 Midway between side and shoulder level (flexion and/or abduction limited to 45) 30 20 At shoulder level (flexion and/or abduction limited to 90) 20 20 5202 Humerus, other impairment of: Loss of head of (flail shoulder) 80 70 Nonunion of (false flail joint) 60 50 Fibrous union of 50 40 Recurrent dislocation of at scapulohumeral joint. With frequent episodes and guarding of all arm movements 30 20 With infrequent episodes, and guarding of movement only at shoulder level (flexion and/or abduction limited to 90) 20 20 Malunion of: Marked deformity 30 20 Moderate deformity 20 20 5203 Clavicle or scapula, impairment of: Dislocation of 20 20 Nonunion of: With loose movement 20 20 Without loose movement 10 10 Malunion of 10 10 Or rate on impairment of function of contiguous joint. The Elbow and Forearm Rating Major Minor 5205 Elbow, ankylosis of: Unfavorable, at an angle of less than 50 or with complete loss of supination or pronation 60 50 Intermediate, at an angle of more than 90, or between 70 and 50 50 40 Favorable, at an angle between 90 and 70 40 30 5206 Forearm, limitation of flexion of: Flexion limited to 45 50 40 Flexion limited to 55 40 30 Flexion limited to 70 30 20 Flexion limited to 90 20 20 Flexion limited to 100 10 10 Flexion limited to 110 0 0 5207 Forearm, limitation of extension of: Extension limited to 110 50 40 Extension limited to 100 40 30 Extension limited to 90 30 20 Extension limited to 75 20 20 Extension limited to 60 10 10 Extension limited to 45 10 10 5208 Forearm, flexion limited to 100 and extension to 45 20 20 5209 Elbow, other impairment of Flail joint 60 50 Joint fracture, with marked cubitus varus or cubitus valgus deformity or with ununited fracture of head of radius 20 20 5210 Radius and ulna, nonunion of, with flail false joint 50 40 5211 Ulna, impairment of: Nonunion in upper half, with false movement: With loss of bone substance (1 inch (2 5 cms.) or more) and marked deformity 40 30 Without loss of bone substance or deformity 30 20 Nonunion in lower half 20 20 Malunion of, with bad alignment 10 10 5212 Radius, impairment of: Nonunion in lower half, with false movement: With loss of bone substance (1 inch (2.5 cms.) or more) and marked deformity 40 30 5212 Radius, impairment of: (cont.) Without loss of bone substance or deformity 30 20 Nonunion in upper half 20 20 Malunion of, with bad alignment 10 10 5213 Supination and pronation, impairment of: Loss of (bone fusion): The hand fixed in supination or hyperpronation 40 30 The hand fixed in full pronation 30 20 The hand fixed near the middle of the arc or moderate pronation 20 20 Limitation of pronation: Motion lost beyond middle of arc 30 20 Motion lost beyond last quarter of arc, the hand does not approach full pronation 20 20 Limitation of supination: To 30 or less 10 10 Note: In all the forearm and wrist injuries, codes 5205 through 5213, multiple impaired finger movements due to tendon tie-up, muscle or nerve injury, are to be separately rated and combined not to exceed rating for loss of use of hand. The Wrist Rating Major Minor 5214 Wrist, ankylosis of: Unfavorable, in any degree of palmar flexion, or with ulnar or radial deviation 50 40 Any other position, except favorable 40 30 Favorable in 20 to 30 dorsiflexion 30 20 Note: Extremely unfavorable ankylosis will be rated as loss of use of hands under diagnostic code 5125. 5215 Wrist, limitation of motion of: Dorsiflexion less than 15 10 10 Palmar flexion limited in line with forearm 10 10 Evaluation of Ankylosis or Limitation of Motion of Single or Multiple Digits of the Hand (1) For the index, long, ring, and little fingers (digits II, III, IV, and V), zero degrees of flexion represents the fingers fully extended, making a straight line with the rest of the hand. The position of function of the hand is with the wrist dorsiflexed 20 to 30 degrees, the metacarpophalangeal and proximal interphalangeal joints flexed to 30 degrees, and the thumb (digit I) abducted and rotated so that the thumb pad faces the finger pads. Only joints in these positions are considered to be in favorable position. For digits II through V, the metacarpophalangeal joint has a range of zero to 90 degrees of flexion, the proximal interphalangeal joint has a range of zero to 100 degrees of flexion, and the distal (terminal) interphalangeal joint has a range of zero to 70 or 80 degrees of flexion. (2) When two or more digits of the same hand are affected by any combination of amputation, ankylosis, or limitation of motion that is not otherwise specified in the rating schedule, the evaluation level assigned will be that which best represents the overall disability (i.e., amputation, unfavorable or favorable ankylosis, or limitation of motion), assigning the higher level of evaluation when the level of disability is equally balanced between one level and the next higher level. (3) Evaluation of ankylosis of the index, long, ring, and little fingers: (i) If both the metacarpophalangeal and proximal interphalangeal joints of a digit are ankylosed, and either is in extension or full flexion, or there is rotation or angulation of a bone, evaluate as amputation without metacarpal resection, at proximal interphalangeal joint or proximal thereto. (ii) If both the metacarpophalangeal and proximal interphalangeal joints of a digit are ankylosed, evaluate as unfavorable ankylosis, even if each joint is individually fixed in a favorable position. (iii) If only the metacarpophalangeal or proximal interphalangeal joint is ankylosed, and there is a gap of more than two inches (5.1 cm.) between the fingertip(s) and the proximal transverse crease of the palm, with the finger(s) flexed to the extent possible, evaluate as unfavorable ankylosis. (iv) If only the metacarpophalangeal or proximal interphalangeal joint is ankylosed, and there is a gap of two inches (5.1 cm.) or less between the fingertip(s) and the proximal transverse crease of the palm, with the finger(s) flexed to the extent possible, evaluate as favorable ankylosis. (4) Evaluation of ankylosis of the thumb: (i) If both the carpometacarpal and interphalangeal joints are ankylosed, and either is in extension or full flexion, or there is rotation or angulation of a bone, evaluate as amputation at metacarpophalangeal joint or through proximal phalanx. (ii) If both the carpometacarpal and interphalangeal joints are ankylosed, evaluate as unfavorable ankylosis, even if each joint is individually fixed in a favorable position. (iii) If only the carpometacarpal or interphalangeal joint is ankylosed, and there is a gap of more than two inches (5.1 cm.) between the thumb pad and the fingers, with the thumb attempting to oppose the fingers, evaluate as unfavorable ankylosis. (iv) If only the carpometacarpal or interphalangeal joint is ankylosed, and there is a gap of two inches (5.1 cm.) or less between the thumb pad and the fingers, with the thumb attempting to oppose the fingers, evaluate as favorable ankylosis. (5) If there is limitation of motion of two or more digits, evaluate each digit separately and combine the evaluations. I. Multiple Digits: Unfavorable Ankylosis Rating Major Minor 5216 Five digits of one hand, unfavorable ankylosis of 60 50 Note: Also consider whether evaluation as amputation is warranted. 5217 Four digits of one hand, unfavorable ankylosis of: Thumb and any three fingers 60 50 Index, long, ring, and little fingers 50 40 Note: Also consider whether evaluation as amputation is warranted. 5218 Three digits of one hand, unfavorable ankylosis of: Thumb and any two fingers 50 40 Index, long, and ring; index, long, and little; or index, ring and little fingers 40 30 Long, ring, and little fingers 30 20 Note: Also consider whether evaluation as amputation is warranted. 5219 Two digits of one hand, unfavorable ankylosis of: Thumb and any finger 40 30 Index and long; index and ring; or index and little fingers 30 20 Long and ring; long and little; or ring and little fingers 20 20 Note: Also consider whether evaluation as amputation is warranted. II. Multiple Digits: Favorable Ankylosis Rating Major Minor 5220 Five digits of one hand, favorable ankylosis of 50 40 5221 Four digits of one hand, favorable ankylosis of: Thumb and any three fingers 50 40 Index, long, ring, and little 40 30 5222 Three digits of one hand, favorable ankylosis of: Thumb and any two fingers 40 30 Index, long, and ring; index, long, and little; or index, ring, and little fingers 30 20 Long, ring, and little fingers 20 20 5223 Two digits of one hand, favorable ankylosis of: Thumb and any finger 30 20 Index and long; index and ring; or index and little fingers 20 20 Long and ring; long and little; or ring and little fingers 10 10 III. Ankylosis of Individual Digits Rating Major Minor 5224 Thumb, ankylosis of: Unfavorable 20 20 Favorable 10 10 Note: Also consider whether evaluation as amputation is warranted and whether an additional evaluation is warranted for resulting limitation of motion of other digits or interference with overall function of the hand. 5225 Index finger, ankylosis of: Unfavorable or favorable 10 10 Note: Also consider whether evaluation as amputation is warranted and whether an additional evaluation is warranted for resulting limitation of motion of other digits or interference with overall function of the hand. 5226 Long finger, ankylosis of: Unfavorable or favorable 10 10 Note: Also consider whether evaluation as amputation is warranted and whether an additional evaluation is warranted for resulting limitation of motion of other digits or interference with overall function of the hand. 5227 Ring or little finger, ankylosis of: Unfavorable or favorable 0 0 Note: Also consider whether evaluation as amputation is warranted and whether an additional evaluation is warranted for resulting limitation of motion of other digits or interference with overall function of the hand. IV. Limitation of Motion of Individual Digits Rating Major Minor 5228 Thumb, limitation of motion: With a gap of more than two inches (5.1 cm.) between the thumb pad and the fingers, with the thumb attempting to oppose the fingers 20 20 With a gap of one to two inches (2.5 to 5.1 cm.) between the thumb pad and the fingers, with the thumb attempting to oppose the fingers...................................... 10 10 With a gap of less than one inch (2.5 cm.) between the thumb pad and the fingers, with the thumb attempting to oppose the fingers 0 0 5229 Index or long finger, limitation of motion: With a gap of one inch (2.5 cm.) or more between the fingertip and the proximal transverse crease of the palm, with the finger flexed to the extent possible, or; with extension limited by more than 30 degrees 10 10 With a gap of less than one inch (2.5 cm.) between the fingertip and the proximal transverse crease of the palm, with the finger flexed to the extent possible, and; extension is limited by no more than 30 degrees 0 0 5230 Ring or little finger, limitation of motion: Any limitation of motion 0 0 The Spine Rating General Rating Formula for Diseases and Injuries of the Spine (For diagnostic codes 5235 to 5243 unless 5243 is evaluated under the Formula for Rating Intervertebral Disc Syndrome Based on Incapacitating Episodes): With or without symptoms such as pain (whether or not it radiates), stiffness, or aching in the area of the spine affected by residuals of injury or disease Unfavorable ankylosis of the entire spine 100 Unfavorable ankylosis of the entire thoracolumbar spine 50 Unfavorable ankylosis of the entire cervical spine; or, forward flexion of the thoracolumbar spine 30 degrees or less; or, favorable ankylosis of the entire thoracolumbar spine 40 Forward flexion of the cervical spine 15 degrees or less; or, favorable ankylosis of the entire cervical spine 30 Forward flexion of the thoracolumbar spine greater than 30 degrees but not greater than 60 degrees; or, forward flexion of the cervical spine greater than 15 degrees but not greater than 30 degrees; or, the combined range of motion of the thoracolumbar spine not greater than 120 degrees; or, the combined range of motion of the cervical spine not greater than 170 degrees; or, muscle spasm or guarding severe enough to result in an abnormal gait or abnormal spinal contour such as scoliosis, reversed lordosis, or abnormal kyphosis 20 Forward flexion of the thoracolumbar spine greater than 60 degrees but not greater than 85 degrees; or, forward flexion of the cervical spine greater than 30 degrees but not greater than 40 degrees; or, combined range of motion of the thoracolumbar spine greater than 120 degrees but not greater than 235 degrees; or, combined range of motion of the cervical spine greater than 170 degrees but not greater than 335 degrees; or, muscle spasm, guarding, or localized tenderness not resulting in abnormal gait or abnormal spinal contour; or, vertebral body fracture with loss of 50 percent or more of the height 10 Note (1): Evaluate any associated objective neurologic abnormalities, including, but not limited to, bowel or bladder impairment, separately, under an appropriate diagnostic code. Note (2): (See also Plate V.) For VA compensation purposes, normal forward flexion of the cervical spine is zero to 45 degrees, extension is zero to 45 degrees, left and right lateral flexion are zero to 45 degrees, and left and right lateral rotation are zero to 80 degrees. Normal forward flexion of the thoracolumbar spine is zero to 90 degrees, extension is zero to 30 degrees, left and right lateral flexion are zero to 30 degrees, and left and right lateral rotation are zero to 30 degrees. The combined range of motion refers to the sum of the range of forward flexion, extension, left and right lateral flexion, and left and right rotation. The normal combined range of motion of the cervical spine is 340 degrees and of the thoracolumbar spine is 240 degrees. The normal ranges of motion for each component of spinal motion provided in this note are the maximum that can be used for calculation of the combined range of motion. Note (3): In exceptional cases, an examiner may state that because of age, body habitus, neurologic disease, or other factors not the result of disease or injury of the spine, the range of motion of the spine in a particular individual should be considered normal for that individual, even though it does not conform to the normal range of motion stated in Note (2). Provided that the examiner supplies an explanation, the examiners assessment that the range of motion is normal for that individual will be accepted. Note (4): Round each range of motion measurement to the nearest five degrees. Note (5): For VA compensation purposes, unfavorable ankylosis is a condition in which the entire cervical spine, the entire thoracolumbar spine, or the entire spine is fixed in flexion or extension, and the ankylosis results in one or more of the following: difficulty walking because of a limited line of vision; restricted opening of the mouth and chewing; breathing limited to diaphragmatic respiration; gastrointestinal symptoms due to pressure of the costal margin on the abdomen; dyspnea or dysphagia; atlantoaxial or cervical subluxation or dislocation; or neurologic symptoms due to nerve root stretching. Fixation of a spinal segment in neutral position (zero degrees) always represents favorable ankylosis. Note (6): Separately evaluate disability of the thoracolumbar and cervical spine segments, except when there is unfavorable ankylosis of both segments, which will be rated as a single disability. 5235 Vertebral fracture or dislocation 5236 Sacroiliac injury and weakness 5237 Lumbosacral or cervical strain 5238 Spinal stenosis 5239 Spondylolisthesis or segmental instability 5240 Ankylosing spondylitis 5241 Spinal fusion 5242 Degenerative arthritis, degenerative disc disease other than intervertebral disc syndrome (also, see either DC 5003 or 5010) 5243 Intervertebral disc syndrome: Assign this diagnostic code only when there is disc herniation with compression and/or irritation of the adjacent nerve root; assign diagnostic code 5242 for all other disc diagnoses. 5244 Traumatic paralysis, complete: Paraplegia: Rate under diagnostic code 5110 Quadriplegia: Rate separately under diagnostic codes 5109 and 5110 and combine evaluations in accordance with 4.25. Note: If traumatic paralysis does not cause loss of use of both hands or both feet, it is incomplete paralysis. Evaluate residuals of incomplete traumatic paralysis under the appropriate diagnostic code (e.g., 4.124a, Diseases of the Peripheral Nerves). Evaluate intervertebral disc syndrome (preoperatively or postoperatively) either under the General Rating Formula for Diseases and Injuries of the Spine or under the Formula for Rating Intervertebral Disc Syndrome Based on Incapacitating Episodes, whichever method results in the higher evaluation when all disabilities are combined under 4.25. Formula for Rating Intervertebral Disc Syndrome Based on Incapacitating Episodes With incapacitating episodes having a total duration of at least 6 weeks during the past 12 months 60 With incapacitating episodes having a total duration of at least 4 weeks but less than 6 weeks during the past 12 months 40 With incapacitating episodes having a total duration of at least 2 weeks but less than 4 weeks during the past 12 months 20 With incapacitating episodes having a total duration of at least one week but less than 2 weeks during the past 12 months 10 Note (1): For purposes of evaluations under diagnostic code 5243, an incapacitating episode is a period of acute signs and symptoms due to intervertebral disc syndrome that requires bed rest prescribed by a physician and treatment by a physician. Note (2): If intervertebral disc syndrome is present in more than one spinal segment, provided that the effects in each spinal segment are clearly distinct, evaluate each segment on the basis of incapacitating episodes or under the General Rating Formula for Diseases and Injuries of the Spine, whichever method results in a higher evaluation for that segment. Plate V Range of Motion of Cervical and Thoracolumbar Spine   The Hip and Thigh Rating 5250 Hip, ankylosis of: Unfavorable, extremely unfavorable ankylosis, the foot not reaching ground, crutches necessitated 903 Intermediate 70 Favorable in flexion at an angle between 20 and 40 and slight adduction or abduction 60 5251 Thigh, limitation of extension of: Extension limited to 5 10 5252 Thigh, limitation of flexion of: Flexion limited to 10 40 Flexion limited to 20 30 Flexion limited to 30 20 Flexion limited to 45 10 5253 Thigh, impairment of: Limitation of abduction of, motion lost beyond 10 20 Limitation of adduction of, cannot cross legs 10 Limitation of rotation of, cannot toe-out more than 15, affected leg 10 5254 Hip, flail joint 80 5255 Femur, impairment of: Fracture of shaft or anatomical neck of: With nonunion, with loose motion (spiral or oblique fracture) 80 With nonunion, without loose motion, weightbearing preserved with aid of brace. 60 Fracture of surgical neck of, with false joint 60 Malunion of: Evaluate under diagnostic codes 5256, 5257, 5260, or 5261 for the knee, or 5250-5254 for the hip, whichever results in the highest evaluation. 3Entitled to special monthly compensation. The Knee and Leg Rating 5256 Knee, ankylosis of: Extremely unfavorable, in flexion at an angle of 45 or more 60 In flexion between 20 and 45 50 In flexion between 10 and 20 40 Favorable angle in full extension, or in slight flexion between 0 and 10 30 5257 Knee, other impairment of: Recurrent subluxation or instability: Unrepaired or failed repair of complete ligament tear causing persistent instability, and a medical provider prescribes both an assistive device (e.g., cane(s), crutch(es), walker) and bracing for ambulation 30 One of the following: (a) Sprain, incomplete ligament tear, or repaired complete ligament tear causing persistent instability, and a medical provider prescribes a brace and/or assistive device (e.g., cane(s), crutch(es), walker) for ambulation. (b) Unrepaired or failed repair of complete ligament tear causing persistent instability, and a medical provider prescribes either an assistive device (e.g., cane(s), crutch(es), walker) or bracing for ambulation 20 Sprain, incomplete ligament tear, or complete ligament tear (repaired, unrepaired, or failed repair) causing persistent instability, without a prescription from a medical provider for an assistive device (e.g., cane(s), crutch(es), walker) or bracing for ambulation 10 Patellar instability: A diagnosed condition involving the patellofemoral complex with recurrent instability after surgical repair that requires a prescription by a medical provider for a brace and either a cane or a walker 30 A diagnosed condition involving the patellofemoral complex with recurrent instability after surgical repair that requires a prescription by a medical provider for one of the following: A brace, cane, or walker 20 A diagnosed condition involving the patellofemoral complex with recurrent instability (with or without history of surgical repair) that does not require a prescription from a medical provider for a brace, cane, or walker 10 Note (1): For patellar instability, the patellofemoral complex consists of the quadriceps tendon, the patella, and the patellar tendon. Note (2): A surgical procedure that does not involve repair of one or more patellofemoral components that contribute to the underlying instability shall not qualify as surgical repair for patellar instability (including, but not limited to, arthroscopy to remove loose bodies and joint aspiration). 5258 Cartilage, semilunar, dislocated, with frequent episodes of locking, pain, and effusion into the joint 20 5259 Cartilage, semilunar, removal of, symptomatic. 10 5260 Leg, limitation of flexion of: Flexion limited to 15 30 Flexion limited to 30 20 Flexion limited to 45 10 Flexion limited to 60 0 5261 Leg, limitation of extension of: Extension limited to 45 50 Extension limited to 30 40 Extension limited to 20 30 Extension limited to 15 20 Extension limited to 10 10 Extension limited to 5 0 5262 Tibia and fibula, impairment of: Nonunion of, with loose motion, requiring brace 40 Malunion of: Evaluate under diagnostic codes 5256, 5257, 5260, or 5261 for the knee, or 5270 or 5271 for the ankle, whichever results in the highest evaluation Medial tibial stress syndrome (MTSS), or shin splints: Requiring treatment for no less than 12 consecutive months, and unresponsive to surgery and either shoe orthotics or other conservative treatment, both lower extremities 30 Requiring treatment for no less than 12 consecutive months, and unresponsive to surgery and either shoe orthotics or other conservative treatment, one lower extremity 20 Requiring treatment for no less than 12 consecutive months, and unresponsive to either shoe orthotics or other conservative treatment, one or both lower extremities 10 Treatment less than 12 consecutive months, one or both lower extremities 0 5263 Genu recurvatum (acquired, traumatic, with weakness and insecurity in weight-bearing objectively demonstrated) 10 The Ankle Rating 5270 Ankle, ankylosis of: In plantar flexion at more than 40, or in dorsiflexion at more than 10 or with abduction, adduction, inversion or eversion deformity 40 In plantar flexion, between 30 and 40, or in dorsiflexion, between 0 and 10 30 30 In plantar flexion, less than 30 20 5271 Ankle, limited motion of: Marked (less than 5 degrees dorsiflexion or less than 10 degrees plantar flexion).. 20 Moderate (less than 15 degrees dorsiflexion or less than 30 degrees plantar flexion) 10 5272 Subastragalar or tarsal joint, ankylosis of: In poor weight-bearing position 20 ,,,,,, 20 In good weight-bearing position 10 5273 Os calcis or astragalus, malunion of: Marked deformity 20 ,,,., ,,,,,,,, .,,,,, 20 Moderate deformity 10 5274 Astragalectomy 20 Shortening of the Lower Extremity Rating 5275 Bones, of the lower extremity, shortening of: Over 4 inches (1 0.2 cms.) 603 3 60 3-1/2 to 4 inches (8.9 cms. to 10.2 cms.) 503 3 to 3-1/2 inches (7.6 cms.to 8.9 cms.) 40 2-1/2 to 3 inches (6.4 cms. to 7.6 cms.) 30 30 2 to 2-1/2 inches (5.1 cms. to 6.4 cms.) 20 20 1-1/4 to 2 inches (3.2 cms. to 5.1 cms.) 10 Note: Measure both lower extremities from anterior superior spine of the ilium to the internal malleolus of the tibia. Not to be combined with other ratings for fracture or faulty union in the same extremity. 3Also entitled to special monthly compensation. The Foot Rating 5269 Plantar fasciitis: No relief from both non-surgical and surgical treatment, bilateral 30 No relief from both non-surgical and surgical treatment, unilateral 20 Otherwise, unilateral or bilateral 10 Note (1): With actual loss of use of the foot, rate 40 percent. Note (2): If a veteran has been recommended for surgical intervention, but is not a surgical candidate, evaluate under the 20 percent or 30 percent criteria, whichever is applicable. 5276 Flatfoot, acquired: Pronounced; marked pronation, extreme tenderness of plantar surfaces of the feet, marked inward displacement and severe spasm of the tendo achillis on manipulation, not improved by orthopedic shoes or appliances: Bilateral 50 ,.,, ,,,,.,,,,,,,,.,,,,,.,,, , ,,,,,,,,,,,,,,,,,,,,, 50 Unilateral 30 Severe; objective evidence of marked deformity (pronation, abduction, etc.), pain on manipulation and use accentuated, indication of swelling on use, characteristic callosities: Bilateral 30 Unilateral 20 , ,, ,,,,,,,,,,, 20 Moderate; weight-bearing line over or medial to great toe, inward bowing of the tendo achillis, pain on manipulation and use of the feet, bilateral or unilateral 10 Mild: symptoms relieved by built-up shoe or arch support 0 5277 Weak Foot, bilateral: A symptomatic condition secondary to many constitutional conditions, characterized by atrophy of the musculature, disturbed circulation, and weakness: Rate the underlying condition, minimum rating 10 5278 Claw foot (pes cavus), acquired: Marked contraction of plantar fascia with dropped forefoot, all toes hammer toes, very painful callosities, marked varus deformity: Bilateral 50 Unilateral 30 All toes tending to dorsiflexion, limitation of dorsiflexion at ankle to right angle, shortened plantar fascia, and marked tenderness under metatarsal heads: Bilateral 30 Unilateral 20 Great toe dorsiflexed, some limitation of dorsiflexion at ankle, definite tenderness under metatarsal heads: Bilateral 10 Unilateral 10 Slight 0 5279 Metatarsalgia, anterior (Mortons disease), unilateral, or bilateral 10 5280 Hallux valgus, unilateral: Operated with resection of metatarsal head 10 Severe, if equivalent to amputation of great toe 10 5281 Hallux rigidus, unilateral, severe: Rate as hallux valgus, severe. Note: Not to be combined with claw foot ratings. 5282 Hammer toe: All toes, unilateral without claw foot 10 Single toes 0 5283 Tarsal, or metatarsal bones, malunion of, or nonunion of: Severe 30 Moderately severe 20 Moderate 10 Note: With actual loss of use of the foot, rate 40 percent. 5284 Foot injuries, other: Severe 30 Moderately severe 20 Moderate 10 Note: With actual loss of use of the foot, rate 40 percent. The Skull Rating 5296 Skull, loss of part of, both inner and outer tables: With brain hernia 80 Without brain hernia: Area larger than size of a 50-cent piece or 1.140 in2 (7.355 cm2 ) 50 Area intermediate 30 Area smaller than the size of a 25-cent piece or 0.716 in2 (4.619 cm2 ) 10 Note: Rate separately for intracranial complications. The Ribs Rating 5297 Ribs, removal of: More than six 50 Five or six 40 Three or four 30 Two 20 One or resection of two or more ribs without regeneration 10 Note (1): The rating for rib resection or removal is not to be applied with ratings for purulent pleurisy, lobectomy, pneumonectomy or injuries of pleural cavity. Note (2): However, rib resection will be considered as rib removal in thoracoplasty performed for collapse therapy or to accomplish obliteration of space and will be combined with the rating for lung collapse, or with the rating for lobectomy, pneumonectomy or the graduated ratings for pulmonary tuberculosis. The Coccyx Rating 5298 Coccyx, removal of: Partial or complete, with painful residuals 10 Without painful residuals 0 (Authority: 38 U.S.C. 1155) [29 FR 6718, May 22,1964, as amended at 34 FR 5062, Mar. 11, 1969; 40 FR 42536, Sept. 15, 1975; 41 FR 11294, Mar. 18, 1976; 43 FR 45350, Oct. 2, 1978; 51 FR 6411, Feb. 24, 1986; 61 FR 20439, May 7, 1996; 64 FR 32410, June 17, 1999; 67 FR 48785, July 26, 2002; 67 FR 54349, Aug. 22, 2002; 68 FR 51456, Aug. 27, 2003; 69 FR 32450, June 10, 2004; 80 FR 42041, July 16, 2015; 85 FR 76460, Nov. 30, 2020; 85 FR 85523, Dec. 29, 2020; 86 FR 8142, Feb. 4, 2021] Supplement Highlights references: 16(1), 26(2), 30(1), 31(1), 33(1), 35(1), 55(1), 63(1), 64(1). Table II Ratings for Multiple Losses of Extremities with Dictators Rating Code and 38 CFR Citation Impairment of other extremity Impairment of one extremity Anatomical loss or loss of use below elbow Anatomical loss or loss of use below knee Anatomical loss or loss of use above elbow (preventing use of prosthesis)  Anatomical loss or loss of use above knee (preventing use of prosthesis) Anatomical loss near shoulder (preventing use of prosthesis)  Anatomical loss near hip (preventing use of prosthesis) Anatomical loss or loss of use below elbowM Codes M-1 a, b, or c, 38 CFR 3.350(c)(1)(i)L Codes L-1 d, e, f, or g, 38 CFR 3.350(b)M 1/2 Code M-5, 38 CFR 3.350(f)(1)(x)L 1/2 Code L-2 c, 38 CFR 3.350(f)(1)(vi)N Code N-3, 38 CFR 3.350(f)(1)(xi)M Code M-3 c, 38 CFR 3.350(f)(1)(viii) Anatomical loss or loss of use below knee3.350(b)L Codes L-1 a, b, or c, 38 CFR 3.350 (1)(iii)L 1/2 Code L-2 b, 38 CFR 3.350(f)(1)(i)L 1/2 Code L-2 a, 38 CFR 3.350(f)(1)(iv)M Code M-3 b, 38 CFR 3.350(f) (1)(ii)M Code M-3 a, 38 CFR 3.350(f) Anatomical loss or loss of use above elbow (preventing use of prosthesis)N Code N-1, 38 CFR 3.350(d)(1)M Code M-2 a, 38 CFR 3.350(c) (1)(iii)N 1/2 Code N-4 38 CFR 3.350(f) (1)(ix)M 1/2 Code M-4 c, 38 CFR 3.350(f) (1)(xi) Anatomical loss or loss of use above knee (preventing use of prosthesis)M Code M-2 a, 38 CFR 3.350(c) (1)(ii)M 1/2 Code M-4 b, 38 CFR 3.350(f) (1)(vii)M 1/2 Code M-4 a, 38 CFR 3.350(f) (1)(v)Anatomical loss near shoulder (preventing use of prosthesis)O Code O-1, 38 CFR 3.350(e) (1)(i)N Code N-2 b, 38 CFR 3.350(d) (3) Anatomical loss near hip (preventing use of prosthesis)N Code N-2 a, 38 CFR 3.350(d) (2) No34DEjuz  U   Y w Z [    !"&(JXhlB*OJQJaJph!hQDhlB*OJQJaJphhJ5CJOJQJhJCJOJQJhJ5:OJQJhJ5:>*OJQJhJOJQJhJ5OJQJ@4DEju U   Y w Z [ $ a$ T $ 8<T# a$ $ 8<#a$ $ 8!a$ 8$a$[ !"A"f 8<T# gdl$ 8<T# a$ 8<T#  T $ a$.@ADef !"%=>defiDFs濿洦'hU*hU*5B*OJQJ\aJphhU*B*OJQJaJphhJ5CJOJQJ!hQDhU*B*OJQJaJphhlOJQJhlB*OJQJaJphhJOJQJ!hQDhlB*OJQJaJph9$l 8<T# gdPkggdPkg 8<T#  ]  8<T#  T "$ 2( Px 4 #\'*.25@9a$gdU*.b3bk*W^'>ZnnnnnnnnnnnnnnnnnnnnffhPkgOJQJ)hQDhPkgB*CJOJQJ^JaJph#hPkgB*CJOJQJ^JaJphhJCJOJQJ!hQDhPkgB*OJQJaJphhJOJQJhJ5OJQJhJ5CJOJQJhU*B*OJQJaJph!hQDhU*B*OJQJaJph'hU*hU*5B*OJQJ\aJph&  !#$%&VkloI|}6ų}}}}}hJ5OJQJ)hQDhPkgB*CJOJQJ^JaJph/hPkghPkg5B*CJOJQJ\^JaJph#hPkgB*CJOJQJ^JaJphhJ5CJOJQJhJOJQJhPkgOJQJ!hQDhPkgB*OJQJaJphhPkgB*OJQJaJph167WX: 8<T# gd]@ 8<T#  ] gd]@$ 8<T# a$"$ 2( Px 4 #\'*.25@9a$gdj T  8<T#  ] 67;WX\]_ 9:;Dlm$㰦ss!hQDh]@B*OJQJaJph'hjhj5B*OJQJ\aJphhjB*OJQJaJphhJCJOJQJ!hjhJB*OJQJaJph!hQDhjB*OJQJaJphhjOJQJhj5OJQJhJOJQJhJ5OJQJhJ5CJOJQJ'$%)XY  $>?qr#%UZ[\`#VWX\^ؼز'h]@h]@5B*OJQJ\aJphhJCJOJQJhHOJQJhJ5OJQJhJ5CJOJQJhJOJQJ!hQDh]@B*OJQJaJphh]@B*OJQJaJph8Z[WXz  ! 1 Q 8<T#  8<T# P"$ 2( Px 4 #\'*.25@9a$gd]@$ 8<T# a$ 8<T#  ]  T ^xz~         ! % ' ( / 0 1 5 7 O Q U W  !!!"!;!*OJQJhJCJOJQJhJOJQJhJ5OJQJ6$$%a&_'!( ))))))))*Q** 8<T !# $ 8<T# a$ T!gdaRo TX gdaRo*$ 2( Px 4 #\'*.25@9h^h`a$gdq\ 8<T# &#&$&G&H&`&a&j&t&u&&&&&&&&&&&&&&'' '''/'0'R'S'^'_'h'''''''''''''( ( ( (!(*(G(H(h(i(((((((((((() ) ))2)3)W)X)w)x))))'hq\hq\5B*OJQJ\aJphhq\B*OJQJaJph!hQDhq\B*OJQJaJphP)))))))))**Q*~*****+<+O+g+h+l+~++++++,7,g,~,,,,,----;-<-e-~----..W.~.............// /$/ԹԹh*B*OJQJaJph!hQDh*B*OJQJaJphhJCJOJQJhJOJQJhJ5OJQJhaRo6OJQJhaRoOJQJhq\5OJQJC***<+O+g+h+++++7,g,,,,--;-<-e---.$ 8<T# a$ 8<T !#  8<T !# .W......%/m///)0U000011"$ 2( Px 4 #\'*.25@9a$gd{ 8<T#  8<T# gd* 8<T# 8<T !#  8<T !# $/%/'/I/J/V/l/m/n///////0)0U00000000000001111A1B1c1d1111111111hJ5OJQJh{B*OJQJaJph!hQDh{B*OJQJaJph'h{h{5B*OJQJ\aJphh{OJQJhJCJEH OJQJh*OJQJ!hQDh*B*OJQJaJphh*B*OJQJaJphhJOJQJ.1111'2h222!3R3S344'4(4Q44445Q5f5g5h5 8<T#  8<T# gd{ 8<T# 11111111222&2'2h222223!3$3=3>3N3R3S3W3u3v333333333444'4(4Q44444455Q5f5dzhJ5OJQJhaOJQJhaB*OJQJaJph!hQDhaB*OJQJaJph'haha5B*OJQJ\aJphhJOJQJh{B*OJQJaJph!hQDh{B*OJQJaJphh{OJQJhJCJOJQJ3f5g5h55555555556 6 666666768696=6N6_6`6a6b6f66666666666666666777777G7N7W7X7Y7i7j7777hJ5:OJQJhy >*OJQJhJ>*OJQJhJCJEH OJQJhJCJOJQJhJCJEHOJQJhJCJEH OJQJhJ5OJQJhJ:CJOJQJhJOJQJ8>D>E>>>>?8?V?W??@8@j@k@@A8AAAAB8BBBBhJ5OJQJhJCJEH OJQJhJOJQJZ<<<<<<=1=L=h=====D>E>>>V?W?j@$ 8<TX # a$ `8<TX #  h`8<TX # $ 8<T# a$ h8<TX # j@k@AABBBBBBBBC\CCCCCCC"D#DeD$ 8<T# a$$ 8<TX # a$ 8<TX # $ 8<TX # a$BBBBBBBBBCC9C\CCCCCCCCCCD"D#D9DeDDDDDDDDEE9E]EzE{EEEEEEF&F9FCFDFHFhFiFFFFG GG9GGGGGGGGGGGGhJ5:OJQJhJ>*OJQJhJCJEH OJQJhJCJOJQJhJ5OJQJhJ:CJOJQJhJOJQJhy OJQJFeDDDDDDE]EzE{EEEE&FCFDFhFiFFF GGGG 8<T# $ 8<TX # a$$ 8<T# a$ 8<TX # GGGGGGGHHH HLHHH.IMINIII h8<T# gd ` h8<T# $ 8<T# 0]0a$ 8<T0]0 8<T# 0]0 8<T 8<T# GHHH HHH H&HJHKHLHNHHHHHHHHHHHHHHHHHIII-I.I0IHIIIJIKILIMINIRIIżŴŴӴw!hQDhSB*OJQJaJph'hShS5B*OJQJ\aJphh `CJEH OJQJhJCJEH OJQJh `OJQJh `5OJQJh `B*OJQJaJph!hQDh `B*OJQJaJphhJ5OJQJhJOJQJhJ5:OJQJ+IIIIIIIIJ-JIJJJKJLJRJkJlJmJnJoJwJJJJJJJJJJJJJKKKKK KJKKKLKMKSKwKKKKKKKKKKKKKKKL L LLL$L%L'LHLǻǻǻǻǻǻǻ!hShSB*OJQJaJphhJCJEH OJQJhJOJQJhJ5OJQJhSOJQJ!hQDhSB*OJQJaJphhSB*OJQJaJphCI-JKJLJmJnJJJJJJKKLKMKKKKKK%L\L]L~LLL$ 8<T# a$ 8<T# h8<T# HLILXL\L]LaL~LLLLLLLLMMM(MKMLMPMMMMMMMMMMNNNN!N"N#N8N@NMNQN~NNNNNNNO!O_O`OdOOOOعذا؜ؓhJ6OJQJhJ5:OJQJhy >*OJQJhJ>*OJQJhJCJEH OJQJhJCJOJQJhJ5OJQJhJOJQJ!hQDhSB*OJQJaJphhSB*OJQJaJph7LLLMM(MKMLMMMMMMMNNNN"N#N8N$ 8<T# 0]0a$ 8<T# 0]0 8<T$ 8<T# a$ 8<T# 8N@NMN~NNNNN!O_O`OOOOPPbPcPPPPP$ 8<T# a$ 8<T@X #  8<T0X # 8<TX #  ! t"OOOOOOOOOOPPPPPPPPPP1P2PAPBPCPYPZP[PbPcPgPyPPPPPPQ&Q>QiQyQQQQQQQQQQQQQRR3R4R8R^RؽصhB*OJQJaJph!hQDhB*OJQJaJphhOJQJhJCJOJQJhJ5OJQJh 9OJQJhJOJQJh 9B*OJQJaJph!hQDh 9B*OJQJaJph;PP&QiQQQQR3R4R^R_RvRRRRRSS"S#S4S5S 8<T$ 8<T# a$ 8<TXX # 8<TX # ^R_RgRvRRRRRRSSS"S#S$S4S5SKSSS`SdSgS{S|SSSSTT0TcTdTgThTTTTTTTU U+UIUJUNUgUuUvUxUUUUUUV:V|VVVVWWWDWpWWX5X6X:XgXxXyX}XƽhJ5OJQJhJ6OJQJhJ5:OJQJhJ>*CJOJQJhJ>*OJQJhJOJQJhJCJOJQJJ5SKSSS`S{S|SSST0TcTdTTTTTT U+UIUJUuUvU$ 8<T# a$ 8<TX #  ! t"$ 8<TX # a$vUUUUU:V|VVWWpWW5X6XxXyXXXX$ 8<T# a$ 8<TX #$  & 8<T ` X #$ %  8<TX #$ %  8<TX # }XXXXXY YWYgYxYYYYYYYZ,ZLZPZgZqZrZZZZZZZ[$[%[>[?[g[z[[[[[[\\\A\g\{\\\\\\\\]g]]]]]]]]]^^^^-^.^g^^^^^^hJ6OJQJhJ5:OJQJhJ>*OJQJhJ5OJQJhJCJOJQJhJCJOJQJhJOJQJKXY YWYxYYYYYY,ZLZqZrZZ # 8<T00X #$ % $ 8<T# a$ 8<TX #$ %  8<TX #$ %  8<TXX #$ %   8<TX #$ % ZZZZ$[%[>[?[z[[[[[\\A\{\\ # 8<TX0X #$ %  8<TXX #  8<T0X #$ % $ 8<T# a$ 8<TX #   8<T X #$ % \\\\\\]]]]]]]^^-^ ! t"$ 8<TX # a$ 8<T$ 8<TX # a$ 8<TX #$ %  8<TX # $ 8<T# a$ 8<T0X #$ % -^.^g^^^^^Q_R_x_y_________&`O`$a$ 8<T$ 8<TX # a$ 8<T X # 8<TX # $ 8<T# a$^_Q_R_V_g_x_y__________`&`O`Q`S`T`g``agaabgbbcgc{c|ccdgddecedegeeeefgffffgggggghghhhhigiiiijjjgjjkkkgkkhJCJ OJQJhJ6OJQJhJ5:OJQJhJ>*OJQJhJCJOJQJhJ5OJQJhJOJQJKO`S`T`{c|ccedeeeffgghhiijjkkkkll $0^`0a$ $0^`0a$ 8<TX #  !kkklgllllmgmmmmn)n*n8n9ncngnknxnyn}nnnnnnnoo7o8o\ogoooooooop p p-pcpgpppppppppq0q1qNqgqqqqqqrrr+r,r-r.r/r?r@rgrirqrhJCJOJQJhJ6OJQJhJ5OJQJhJ>*OJQJhJCJ OJQJhJOJQJOlmm)n*n8n9ncnknxnynnnnn7o8o\oooo$ 8<T# a$ 8<TX #  ! t" $0^`0a$ $0^`0a$ $0^`0a$oo p p-pcpppppp0q1qNqqqqrr+r,r-r.r/r 8<TX # 8<T$ 8<T# a$ 8<TX # /r?r@rirqr~rrrrrrs>s?swsxssss t!t$ 8<T# a$ 8<TX #  ! t" $0^`0a$ 8<TX # 8<Tqr~rrrrrrrrrss>s?sCsgswsxssssst t!t%tWtXtgtutttttu uu1u2u:uGuKubucuguwuuuuuvdvevgvivvvvvvvwgwwwwwwwwwwxgxxxxxxxxxxxhJ>*OJQJhJCJOJQJhJ5OJQJhJOJQJhJ6OJQJS!tWtXtutttt uu2u:uGubucuwuuudvevvv $8^8`a$ ! t"$ 8<TX # a$ 8<T$ 8<T# a$ 8<TX # vvvwwwwwwxxxxxxyyy zzz ! t"$ 8<TX # a$ 8<T$ 8<T# a$ $8^8`a$ 8<TX # xygyyyyyz z zzz#zBzCzgzzzzzz{{U{g{{{{{||(|)|-|[|\|g||||} }A}B}g}}}}~ ~)~*~.~]~^~g~}~~~~~~~~~~~~~~~~~~~~hJ5:OJQJhy >*OJQJhJCJOJQJhJ6OJQJhJ5OJQJhJ>*OJQJhJOJQJJzBzCzzzzz{U{{{{|(|)|[|\||| }A}B}}} ~)~*~$ 8X # a$$ 8<T# a$*~]~^~}~~~~~~~~~~~~~~~~~~~$a$ !t" $ 8<Ta$ 8<T 8<T!# $ 8<T# a$$ 8X # a$~~~Th56fgh>cdh܁݁+hzɂfhbhTh=hOPYhhhhhhhJCJ OJQJhJCJOJQJhJ5CJOJQJX~~T56fg>cd܁݁+zɂf$ 8FT# a$$ 8FT#a$$ h8FT#a$$ 8FT#a$$a$fbT=OP$ 8FT# h^h`a$$ 8FT# h^h`a$$ 8FT#a$$ 8FT# a$ OPYhhh'h 34Z[hrsđőڑۑ<=>HI`abi̒͒78BCͽͽͽͽͽͽͽͽͽͭhJB*CJOJQJaJphhEB*CJOJQJaJph%hQDhEB*CJOJQJaJphhJCJ OJQJhJCJOJQJhJ5CJOJQJBOP 34Z[rsđőڑۑ=ab$ 8FT# h^h`a$$ 8FT#a$$ 8FT# a$bCDhjkl&'$ 8FT# a$$ 8FT# h^h`a$$ 8FT#a$$ 8FT#a$gd<$ 8FT# a$CDHISghiʓ˓ ABrȔɔ ,g,gjkl&'(cӳɩhJ5CJOJQJhJCJOJQJhJCJ OJQJ+h<h<5B*CJOJQJ\aJphh<CJOJQJh<B*CJOJQJaJph%hQDh<B*CJOJQJaJphh<CJ OJQJ:'$%~ KL$ 8FT# a$$a$$`a$$ 8FT#a$$ 8FT# a$$%(c~(c(c (KLMNOPQRSYcdv~ɛŴūhJCJOJQJhJ5OJQJhJOJQJhJ5:OJQJhJ>*OJQJ j}hRsAhoUmHnHuho5CJOJQJ jhRsAhoUmHnHuhJ5CJOJQJhJCJ OJQJhJCJOJQJ2LNPQScdv~ɛSwx$ 8<T# a$ 8<T#  !t" $ 8<Ta$ 8<T$ 8FT# a$$ 8FT# a$gdoSYwx|Ĝ <XY]uv015KLPYhi۞7Ykl{|ʟ˟Ο۟ܟ˺˺˺˺˺hJB*OJQJaJph!hQDh>)B*OJQJaJphh>)B*OJQJaJphhJCJOJQJhJ5OJQJhJOJQJhJCJEH OJQJA <XYuv01KLhi۞ 8<T # $ 8<T# a$ 8<T# 7kl{|˟?@PQbcu} !t"$ 8<T# 0]0a$ 8<T# 0]0 8<T$ 8<T# a$ 8<T# 8<TX# 4?@PQbcosu}ڠ"4orswѡ MUVY𕕕hlXB*OJQJaJph!hQDhlXB*OJQJaJphhlXhJ6OJQJ]hJCJOJQJhJ5OJQJhJ:OJQJhJ5:OJQJhJ>*OJQJhJCJEH OJQJhJOJQJh>)OJQJ1ڠ"rs VK;Ҥ!c 8<T# 0]0gds$ 8<T# a$ 8<T# 0]0 34JKO[\|}ǣУѣ:;?EFlmѤҤ֤ !%PQbcgм'hshs6B*OJQJ]aJphhsOJQJhJOJQJhsB*OJQJaJph!hQDhsB*OJQJaJphJåAVWXY[qrs¦9:>QRy|}ɧʧΧ#Nehijsȴ!hQDh4B*OJQJaJph'h4h45B*OJQJ\aJph!h45B*OJQJ\aJphhsB*OJQJaJph!hQDhsB*OJQJaJphhsOJQJ=W:}ʧija̪ͪ+G$ 8<T# a$ 8<T# 0]0 8<T# 0]0gdsè'(WX#`a̪ͪѪ+G`bchǫ!=>B`efúòòòòòhJCJOJQJhJOJQJhs5OJQJhJ5OJQJ'h4h45B*OJQJ\aJph!hQDh4B*OJQJaJphh4B*OJQJaJph?Gbcǫ!=>efFGŭ@$ 8<T# a$gd`X$ 8<T# a$ 8<T# 0]0ڬ۬:;EFGIvwĭŭɭ̭<@DklӮԮۮ(ABǶǗǗhwB*OJQJaJph!hQDhwB*OJQJaJphhxB*OJQJaJph!hQDhxB*OJQJaJphhJOJQJh`XCJOJQJh`XB*OJQJaJph!hQDh`XB*OJQJaJphh`XOJQJ6@ԮBG԰հ$ 8<T# a$ !t"$ 8<T# 0]0a$ 8<T# 8<T 8<T# 0]0gdx 8<T# 0]0BI_ 5Gp԰հ:"Z)/03PQTVؾسةةؘhiapB*OJQJaJph!hQDhiapB*OJQJaJphhJCJOJQJhJ5:OJQJhJ>*OJQJhJ5OJQJhxOJQJhJOJQJ!hQDhwB*OJQJaJphhwB*OJQJaJph6հ"Z0T>?kl$ 8<T# a$ 8<T#@/ 0]0 8<T# 0]0V^_>?Ckl̵͵ε޵ߵOPpqwն7ef89hJCJEH OJQJhJ5:OJQJhJ>*OJQJhJCJOJQJhJ5OJQJhiapB*OJQJaJph!hQDhiapB*OJQJaJphhiapOJQJhJOJQJ=̵͵ε޵ߵOPwն7e 8<T#@/ $ 8<T# a$ !t"$ 8<T# 0]0a$ 8<T 8<T#  8<T# 0]0ef89jk{|$ 8<T# a$gdjQQ 8<T# 0]0gdjQQ !t"$ 8<T# 0]0a$ 8<T# 8<T$ 8<T# a$ 8<T# 0]09;jk{|1GKMhostu~EǶǬǶǶǶǍyy'hUVhjQQ5B*OJQJ\aJph!hjQQ5B*OJQJ\aJphhjQQB*OJQJaJphhjQQCJOJQJ!hQDhjQQB*OJQJaJphhjQQOJQJhjQQ5OJQJhJ5:OJQJhJ>*OJQJhJOJQJhJCJEH OJQJ/Kstqr̺Yqͻ 8<T#@/ 0]0 8<T#@/ 0]0 8<T# $ 8<T# a$ 8<T# 0]0 8<T# 0]0gdjQQ 8<T# gdjQQEFXpqrv̺ҺYqͻһ KqҼGpqʽ˽ҽ[lqʾ˾ҾUfqxÿҿ"3EqƾƾƾhJCJOJQJhJOJQJhJ5OJQJhjQQ5OJQJhjQQOJQJ!hQDhjQQB*OJQJaJphhjQQB*OJQJaJphGͻ KGpʽ˽[lʾ˾Ufxÿ$ 8<T# a$ 8<T#@/ 0]0 8<T# 0]0ÿ"3E5678YZ @AS$ 8<T# a$ 8<T# 0]05678<YZr @AESTrCDH`amr EF_rwɾhJ5:OJQJhJ>*CJOJQJhJ>*OJQJhUV5OJQJhJCJOJQJhg5OJQJhJOJQJhJ5OJQJCSTCD`am 8<T 8<T# 0]0gdUV 8<T#  8<T# 0]0$ 8<T# a$ EF_w23j$ 8<T# a$ !t"$ 8<T# 0]0a$ 8<T# 8<T 8<T`#  8<T# 0]0)*23jkr{|}ABCLrr/0123456789:;KLW_ctyz㼼hg>*OJQJhJCJOJQJhJ5OJQJhJ5:OJQJhJ>*OJQJhJOJQJhJCJEH OJQJJjk{|}AB/$ 8<T# a$ !t"$ 8<T# 0]0a$ 8<T# 0]0 8<T 8<T# /0123456789:;KLW_yz$ 8<T# a$ !t"$ 8<T# 0]0a$ 8<T# 0]0 8<T*+-6 $$Ifa$gdJ$a$gd2-"$ 2p@ P !$`'0*-/a$gd2- 8<T 8<T# tSoz!(*+,-6>"'()>Sh2-h2-CJOJQJ!h2-h2-B*CJOJQJphh2- h2-5:h2-OJQJhJ56OJQJhJ5OJQJhjQQOJQJh#OJQJhgOJQJhX4OJQJhJOJQJ7()stu6$ p@ :$Ifa$gdJ $$Ifa$gd2- $$Ifa$gdJSstu"6789>cdw"12>XYZ[\]"56>DSTUVȹȵӵӵh2-h2-h2-B*OJQJphh2-h2-OJQJh2-h2-CJOJQJ!h2-h2-B*CJOJQJphh2-B*CJOJQJphG6789+ $$Ifa$gdJkd|$$Ifl֞ qK% &0(4 laPyty9dw2Y $$Ifa$gdJ YZ[\+ $$Ifa$gdJkd $$Ifl֞ qK% &0(4 laPyty\]6DT $$Ifa$gdJ TUV+ $$Ifa$gdJkd$$Ifl֞ qK% &0(4 laPyty"29:;<>"3>ABCDEFRhiw;;Uh2-h2-B*OJQJphh2-h2-OJQJh2-!h2-h2-B*CJOJQJphh2-h2-CJOJQJJ"2: $$Ifa$gdJ $IfgdJ :;<+ $$Ifa$gdJkd#$$Ifl֞ qK% &0(4 laPyty $$Ifa$gdJ $IfgdJ +kd$$Ifl֞ qK% &0(4 laPytyBCDEFRiw $$Ifa$gdJ $IfgdJ$ p@ :$Ifa$gdJ +kd=$$Ifl֞ qK% &0(4 laPyty $$Ifa$gdJ $IfgdJ$ p@ :$Ifa$gdJ +&!gd2-gd2-kd$$Ifl֞ qK% &0(4 laPytyte: Need for aid attendance or permanently bedridden qualifies for subpar. L. Code L-1 h, i (38 CFR 3.350(b)). Paraplegia with loss of use of both lower extremities and loss of anal and bladder sphincter control qualifies for subpar. O. Code O-2 (38 CFR 3.350(e)(2). Where there are additional disabilities rated 50% or 100%, or anatomical or loss of use of a third extremity see 38 CFR 3.350(f)(3), (4), or (5). (Authority: 38 U.S.C. 1115)     4.71a- 4.71aSchedule of ratingsmusculoskeletal system 4.71a- (No. 64 3/5/21) "&'()ùhlCJOJQJhjQQCJOJQJhJCJOJQJhJhJCJOJQJjhJ5CJOJQJUhJ5CJOJQJhyjhyUhJOJQJ &'() !# !0]0` 8<T50 P/ =!"#$% Dp}Dd p  s >A?Picture 1"b|pA0|wm4J]|DQn|pA0|wm4J]PNG  IHDR9sRGB|tIDATx^MŕddO%cA$@^0,xB LX$BPPF^xXAAXrXDE`H,aB`#yX0 ^|}v=xt{N}֩5_#8#R#8 l#8@6򢎀#86|8#$ l#,/8#l#8@6򢎀#86|8#$ l#,/8#)?׿{sC??ɾ|饗﮾jG ~&<|<Ƿm%^#0oڰ??cz?[k9}Ʀs΁Ő$  T7NNAaRb_áJ >vmEᴑ5rZ I@O2QgLK9S #n~bLf#m4]dlө=@:ZaHj6`3ӿP2Nela5:B4`Vz qŇw}WHUNa6D1lۭH &^|϶ SP}CLʢ* ً%+f f fC`W:kFl0o6Hwq/q&yӎ# LK_2!7T^)L)RaHr)fg( zh[o|G FX>z-Ťqh9l سgϯ~\Fq"T9#0 4ihTezb ((SzXF]m9v=ސ#8`yF ?N#8@$Y, vd^`"ٴJ9>] ˁ7|3T{-4j _>Kҧ.㩏R\$E/Yn(yc@7[CЗX@%3LE~gq+ 5^Q `З$nX4:CUPxz.=EO  %LZlhlE*U']ĞV\_jRol_߇l!GW6z5/U1bS!?TR|N3`y~qR#w_ve\s wGj뿒nyΝ|[L?n2x6nvߗ&ٯg_=-*hW/g>#K|Rm~҅?pނ3G?Oi=t8#D2l6\$Eɾ[?oE|^7p G0TD/b&:r䈼Qs͋/17nuUBDOp8ډR_n] @mF3DAƮiC&ɔ mdc-~/|>N$=YdfOǂpH*޽뮻0jQkZ O>JB6]@|O%V&:Wl~ O1kWg\Sv\6b=8٩-<|>{,mɩ7 PaSƦ΄BӲP~O>$4a=zVȯxD~`:vVC׹S\r^`$`9s:WI?6VsGkT zovm?(쪊de#Z ()@ XR7!e^":?P^bJ*ނ BOb_XU—z]6:څ/RRv3"P:Pt_K"Fg'pGh0R+TG}ԂpG`*d3Rk׮JϝNGpTkrT8#RgR;8h6!GpVlT ]vG`Eh6V #8@@{;}&9#0W*ۨI5:Wi'8/ dKUaVG`^Xe@{^J&WFv)4*qR8@(͏n(<6Md#*ȏDGy ' .483EMd<ƤG޲3}n4rqVT>BE%y@/"ȈWs}#2e'$߰[y9*+/om4&V.c]݊CVwq뭷RRG DԩSw{eb;v(1IA?slcݺum{x«&tne 3g~,1{IG`<xW@%p IY.:Nda˄u$_نw}8(`ns;Tn \ ly]/5pyN$u5n&u+=mxN/ -&ASvΝ;kkvfoMfFJ0Z$Tͺ#,!{B;C@avYo |),<\ a[#8A`ƍxQ;`! DiQRsw{mcZ8#0{^{;３p[N86wy)L6ܵ7806![qG!n8I#π;ap"G ^dmC. ZߣNEϑ7^#oTx4}O5)$Q[fБ%vA'mEp:M;Ϋ3\pZܚ;Ms5 H8*69=Sc4kBƌuc#1ىKf /D!3gڇ YY/m[nU+$sߗ_~|x C<JDwo߮?ȎLllCRBh3kˌ]{mUlW6% @lٲm6)%j/2(aDs={w3Uwqn_EDAկ~[|6gvo(LRJصkP9×E1 ŐM&%%1Qys%ر,袋X|I@ʨR>O|2lC6/6go3M5Vbkר¹oCUm).bk;w7˶ <|ꩧ:$-rW杇 6.kGpn,g4K쇬oq6Vz7a/LIoBa& }*9AxI.(dmks(fyA_aͬ; Mc!^[UPQ9'\g5o+ kl#M*)"?< ~]G + (.Hc|,%Y8)2~g]%a[e 6ځ-fIC`aLl#0f%G$^\(y=cC% Y&RZs&4*)X8YJ0сcBLDBBG5,bɾ={ 5o&o {Wt?C+Bq|+88Kᆛ6m2? :45muô[k޻.TGűck6LK8p!.%4\\'?z(Kݻ[",[i{0w.c!8pkDʠCnj||ኦSjدAV͔J*tayx¢yU `+Q <" NӅ b2  r  _#&CM:@c9g\vuNMچ؃/72g a>*ʩ[-0{m/V97RYi"L>r<\2GsnZT[pbp'q,IkSthdk^j]v'mSaHWZۘ˳]làEF* ?1h !LCkX]P//96TO5Ǻ]{ꚦhOwI_fC^^"eoAc)p`n u]gi d]o#+e{SU5|PvVd΢E&&Qpӌuga`2#j٘Rl5f֎ʲ}I=JQ^Il6ζ6j@%.͞ؽ >U'հu`Fm LL5Tn `q*ԔXt2i6Xh=u'35kSeTC3%uYfR*;|~IiGR M$sYI@&z]Ah)Kz5KVLR12L 5#3Zب$0;h 8hX,(yi42ANda嶘=OE˕y M27R 58O2٩ e>eіǠ˪>BdLx{c3aN D% ֤eAv G`ɢaH1ԴXd12Am+H e#py c3v=hڎ3 EėEbEб%0bg,WQ6TLGebIsd\Ҳ)UO>ֿ43:Yztxvt T )cDCrD]Zh 7PFWy12ioqM$l-Q6%0°t.3rEd64(R;(DŒw|?X`5-tgbrh6x#7WBdG䜈|+{1Aģs-]dRd%"&5%{a,3-#L. 7 &'βoPb \BF"y,4"s&jޜRJ5V4ar6yl{A_ gᵑH-C.b & n*1ڦYr0E"u'zن+6*UfrB"`eHD:\p0AZh,`-奨)#C͌bHs|_lc A6!ې\lS`nޢi-j ^'C~񓡾fߺ vjSٔ"b-ڊ|]KFFKrLӚR_lC>I &ngt,DZ&D=:T6$Іk.}r@-b Vf_`IӣŠWP]6,P)Eq;;vPQ3$@;5:hMKDƐԚb,1%% #2Zr"b#K6 ]=، Rx>&Vǩߢ_T_E(1Pw(R$,w2Pa֒PPh=/+m5d)PJ[J::V˴(_dP"˚dŠA$73i% HLn!xYeY :s+e;8A .μ[pҊ BM3/a*dKjzqYY=q`G.uIiG֓`oFid//m(aR6(Bf#U.I<(!_sfښ2KsMB_yv%fξ4%f' Dr2*B_{>u m4yQC p},|uL͹mY揘v+#uJ6O^ߺ:\x2BȽRSV*;}Jo@xىz,zm*o@6z$&+Dk"_4Bc`bp\L#\a5S|Q՟=Z@!IЙàQTOM XY5I*_!/BMhۅ R~H۸Fw gbyJi fbQeLM(‰VFR6.[vJ-Pԟ9f {ܺg/Dbi\ΐmH:.a$tu6$0xb"]*T($<Fe{nx$qDgϖwth G ^rU6YiC%L;:hUp_ iʥg(/{Vp3dDRDx,[\pI4!IN]6Z;xdcaTCc H^rxudTgC;$QҢ\ijtu%bHb-h`f+ ȫmXf ڒIUXfkCZi;Wj q;‡-e,NVҡ-4|]Hag6I ;¦/}S<)#i*eurSdHvL-@2GRt2`.ւH䠾ejjќ9iaà,W3BŻ75XaiPtRhΎ |E3sx&pY'wz8%)*{I!ƈ‹y-uBÑFRgaC!ͥ2 h2I1! L^_Gr3H|ŋuD@v `F9>HؓJ,HP`!lOB@%l ,}`K 7M9H6ս]m&ϸT/蕡A (7YTf,O6Ip%v;`m$\X3@jWC[(oJw6jPa.Ekuztдj6dO+S%17Yi~=HSk=_Ȩc&^2-Zk/* 1c,E#iyȞ,FJ/'tPI ;RD}: e  R޼Q?^>H7Jld#֚X㤷R < tݺu05k0rPP7tSjmY?~q,T_u]7|>&i4$FW_͈0]wܹ,0mذ!i|)9p/XuYZ9眳~z^t`T<Ӧhoi6n/eJC`m=so~}Ni3s)^wukdO#%E]駟v-^,{Puokȋ㢈vfKޚj۾}{c0@|T0؎y-C=Zn6 15w}0fx޽=pKUZqF)v Ds-r0}% h( Ř7#Z^W K7bm`ƦZ3~$YJ`EOP^Ʊr>*"PNF#U0[gA"e rIHWreLitivtAH ϐ׳gSًeDI/R`1av؆Vn2iFm$S*ИΜ9X+LOYMk׮>A ٳg1b-ݱcPaWt_GLJqPK/tI^GkfajTpeS5cizz!ՃQNhqϞ=Ofn7v D"ѹ]v1m"R`<\ -gi6upM 9KQKϖh ۰\ 6h̻%Qb.Hp?1 QRg`VGX˼cr2 Tbɛ5OIv6TbM^R`!wL;y.lCVYS_?@vU1M+;`{ ^gbLBc[ldFlDz<}8 n;^う,{Jt6nmLnO.{q81k(b2;˕Xzk'¼&_˜pVsA,1[l%H ei~ph6j66lcBFbZ$1mRC}FRKKg`l"D 2!yI QO[??e{¢+cz`v6j,-n1) GzUvmNrzNT rܒ׶u_$&iq-̲dN0۶mhГ9Wsdt&.2Q'WyEF3ZD BզԄG&_ " 'P:t+En`E,?ktb)1{%(/mL%)<t6RnP^|[+e Y"Tu,iQ+ ժcN>Y7G?rj2ig\0dF FN릵?d5 zQ}$ߑt#.:"1d%heR%Ю*ͺ'ArB6u;U(ϣ$SQVʎVOYI&繽_53HaӖݿz|$@8ۨ@īx?9S9ih+ ,B{Wr0 YV G5U%!׷<'ќgSWl,V&KDB IF(X=@} 2 ]Ɛ$nP2;J+:)t_l!X';UccMwAȭG_5zh,f^Zc<4g*lcMPK\sz^|E7W^z1wU4V9W] c)裏. I6`c[ .Xmr%l27څ0k|N-,5#S+aF(X,[\ur9|~?P6hv2^ʽ9OoIP,M1\TNh(%T I$SX ZgkJ(N#Iz !֥@-怸s Ju , ׈BUfi3U)*y ;ZK}h2Ƕ6_:eD;X*deZbSljX mSm Xʢ\{=B@4쎱 O(D18xj$Hl@3پ pTNz+8 ƞ4nl`32 #L>U3,8D9'UچI7HUdJvC@ 4. e14gY]^ɲƝ"("Lf \#% ͎Wv=(uhIrǃnf~tĉBK}. IDq3*ic1Ɣ7o+2l(mvu>IGRՠ <#+IH֌P-nJo#ε#/-{-0EQ8 Lo\݉Gcj.K"s/~\,lHt]mčJoqG00T~6rtrHHܖ>نToo{1.qT/Be:Z<(Bom}GItnAȱ"@`ǤaQF+t\? 8b=o= {,߷0ӥ67@4Qe*Gā!>`H#hBx.BuU8<+^~(؋C@y[PhƋ(Ly;T? }'gΜٰaC*&դ-#%b ӑ֯猤HM "3|"O<%?~l=7S8 +JH<Gl#W;cz6¨kY7tSPOCOh2ƸXna0|#vM*+M/:JX@ъOH%;22ℵ\Ʌ ]CҢZ jWؒۡV=7n<'e'[M:(! s?S&BH u,5$,$FbXpZ_cdZC(Wz$'*7ؑN|z4!vI1PRCl۠BlY3īz;HS. m| J'&lgnĪ-R3*21,F!:߷lC'):hYR1@drsftūAf1#f`ex(TEbܚ\/x#\}> ,.3G@~!>XE92̉ ܳg.& 7 *CСCLԃVbx?P&I V M>iy$Gu7҈֜ Sq(}Oy.!:o-1悀c̯nϴ LI+jw9gUme.%FSJN>3X~n,I4IɁ^ٸq#U-@Wfi`*sXD'U8=N,.N6_?ٞ 7p$āKZd-@M=#t)Jct)>r4JR"C4O#r2m͏DLL+|ʬJD; 2iH2J)ߌ;֏MWb]"" UdQQ 5Wn2R#Few>*D-Ky"nk$nV+OLCb5'0DOI҆m̌L#+ KO [$1aU(3|ϒ[tMخ#P@ *\'&J*d 0#+n8/[Tғ $sS}Y31[L=etj))ԖfGY0Z' u=!D8hib7aiG"\>]I.mZ9rрc;SD i(̵ ȋLB=OF1tѹTSW%(]2yX[~m#0gmUY:{kxi,eLQw X w,ßAvƩA6FS<ֲ-}fbmghM;%S3jh$&p/qHNܹrmil㗿e!҇e v?zh]" %M;@#|6o7ݛK]M.|;2D(?C S8zT@sUWXآ>-=EA,v6Um`i3-O6vFWShtt 8?<Aܺy\3ٺ* Iݜ+`K[Mb5]yZTWpxbV>m/& 0l;C"  7*99,8Q+}{uA0(%J!EٱMC-Eo֟HR~ ЩXQy*M6QsXfټԤUSXŖ4Z{+. wh Z;a1W;főowJJ\;c@hh"޸qɓ'! ]ᣏ>/'vQ2."D1AEjv⋞5pYfi񯌿$)譨.efP^dT+Rnq!#Ծ}B.,<I:'c# Mw{ İ%2u1I*HLze%\HnlMm,wO-:GQA*$zGJ < <$#vyhUIu*T^D͹zx[%| .r}~#xM҆ _\l#[t ֬<#@%vemU3@eTV0F-|:s\zdu#` `۹QYVSZ&PWvm3 KFMl¦q{^ʼnƢÄH*s1I?Jٍ1|'= N#~W rnj:G cUN5\@C2D[GbjVv| g60K7J9+n(ElCfEyJf{I̾ U˞p4[{)x=214JEH`B T𠃔{VVaGR8xQm`E$Ӛ|mL%lZAS?}L Hk͵hAL`wFg~[9* lC<ս #AlQ7X #B+SiJng2j=.xvКxqe0QT{1 'V"̦I.qֻVw-+;:ޗȈ6l͈$JctNUk }ucPgY0Wv"A)oYZG@hm ^mW.Сm~݋o]oZb4٥ @yIG`($W1)j8Hpٙ IP ߢpTە?뢽Y`v]>(O(P3ҷpFhF;v ڞEV]k; 'o93@rZ_3,5 :8.$Cll=Glc֭~ǖs߿_>C[oK  %K^Id m$#m,qmou^K-O?ݮnHڵo9BꫯO?>*GLX=7|DE/w^p]w#7ڪl@}'̙36lM*o7m ܁͡j v^6ds[Er#+HrJEG`WϠ;waӦM1Ζm۷_r%Px饗)LW2n]] /кppl, :Jn)RpƏ@ېUt<(HH((4DB8@$ nݺUwAU ׭ޚ.\kn!<4! CB8+4O2۰{<^b) )"E:˹HG`Hm Mfk׮ p:P=zHAkw"lG$Tټysi,3@,4ؿ ؛p!`_뻖6nՉ*DoKS~ejӦ9 /K:qdfcPٻ>#pTm4&ktbU# y:FR|xe@Fer%1?pw-. ) vTGy4j"~ ;-Iꫯ7t,.%9|#D_0E-୴S7nEI Y]tdJuf7_,asMxp pr! LH c3b=,xa þoi@UeI06}^m:tqE0܅-REx7I ׻ﾛv=1j׋d-iG&3N @^˭6rwUF$njHεyRdy> $0,p 74CɓO> szkWJQ4K l.|k ࡊ|ody/LNGMShf_vm>e{>M/"T/)<é [4烌+ r3lRæ49Ep&t2Ƙ#0 –2$F?"";un hFEƋ:G(VoxJO+ı#fIn{N_z!ŀJqlkC#Ϫ8z"h)_9mCgy(:5s|oD5G](FyH'Qqt }Ľt`;-G:GpmHrS+%%̃V,08sX Q'KG䉾FWz_T_;_w!ӷ̂(kiEbDU<<qw}/\/Zj6d!.tȑJ,A(D+Ql//~ݱc ɵo[Qa0O=_B'AOA4eaɞ! _|?Q?Q'~@G# @*ꎀ=iN#o[6$l_NlMb@dO/(ˡ!B XB<:s@m**}(¸ UU)F(.p΀2XLݨJ߄2?˂J#6f㓟=@I‡]nl|(Rڲ9>KmyȈ9~MIXiV!'":뭷"%0w5a45矫6w +\6e{%3gg?ve Q' T/F#0 /UJ`fvW_}EJh`-l:>Mco1Wm۶J D[<\-Y-B*1*URZ/{xt^ 퓓aœ1<6zI'~5>`;B6ڃ%_R'B ):.ӿU؆)AJ_SFyF!0XV|>n.q~.Т؏}Q910\>@ {'W ɾ \:#0cpqX:Ik鈘;t<?j"p S?Ea"Չd;A']_IbIXEtS7; ;ғ0B@.lcґT owl(#+Dgk.&v|4w p:ɇ PꁣKm28=9tdmنO)"@d'NpIc6fs!#R ".Ӗnߐ|(HHH7VpNO8#~PΥ=IJ"SQJ 5%\(f4:l<%,ܛ.>!p~8Fđ%t)k1!.ّc 7B@{I0SPtk@.69:7Ȃ|/F[0~Mv{9|R1;H5,*/tD RH6R5/T"[Mz]PI6h ƫܼL."ن˥y=C#QĐlh8 WlSL$CӧIu饗r A 4F;X1ٮ>˝#aƂ_aN$ٜAx+ +#YJя卞r{8qs§@sx&RK: QQͩ`FJМt$Ov=2v%]'"A0g48S9/8x!Ρ()tQ˚wy'9,r0kx7GsΉ$"mD6p9Wٵ4uk2 %z{na2[~@@J`$ws!8udzahگ3<3BҐ 4א{[F 2- $ |;sFA|m۶%&ӜBueo-z@b6V88~8Jez޽K'LuF(TP;9v0'cp <>diJY425qDK^F> m{xb$#hv%%d r4V/ASojIَ) i$jDgcO&ReI!% uapc4!6mlcB㵊9NDTc Vah>:7 <ܥ5kIw3lsaBX&hӘg锣pHbsqc#2-}x65{g`"!eYupb n~Z牀4vF#D^ ?DLqckTo#wJ.PHt׽#iD ma/t2%rf,\$ z%*=/߈@2۸ +"D`E3gܐTZΡquԊW$ [͉LT_e3~gx%7o~'Q8pk$fTeO`MehF')Cgcŧ\zG&6m֭h| |KH! m[n6} {"438^AS r~U7ye8*3gMC¯?C"G4$sm+m̵ޯ@Սh?&d!'\ !*ſq l znȶ;v^yIۦrncѐ(W.+Nu l zn$`E j`M]O~ TyG>K?9K AFvw Z?0r?.3ߜmJA ے"i`a;x]Gw'QӵJe%~gyd]*DƜ#vv~ Z>sԩk^́4g olj`ؑvj/?`K01_tȾ{H:Bzԇ#޻4?#eErpnIì2Uap6SDS&"lailc=Ex衇ED_͏=:$yۺjz뭪"|뮛:A_A7pC^ y#6fp;h6+tͮˣ '-D)5N'8tŨɊ:>f$^Oc9 -ћllz4 [a s=syc:)B;v*zmVJ*\f IL8Kolܸoe)8%SqŽ@r4O,xt(U9w @>jD|-a+/,> v%QjɔXtMaID!cO> Lʧ ht!&ؖk}ՉwAA6]#G ]~ + iw >#ksaiT57ugLR<_! [ƒoQ'{(“jC8@1=]2 u%چeI5 o݊ &l4 >?H|pBB&c$/n\ewޡv|5=vYאovI`a Ȏ^8,#in,`s*f' F|v}S*JiLΘ'N{yewtvF*K,(fmUrS #Ћ!p%WgY%60QR)Ȫ(6SJF$ ,ѽb*WmytrU"YZD6F"1FS gPL$C%Ř6xz).14>}2G^Jf0MLϜ9߄J5,6- .B~HM 1@ >+:Va_сa|;ALjCO#&Kޝ;wZDfAki&!hH s?gϞ6mFOY~T]c\X.z٢76dbIwl,b<Һ=p^㛵2,}g45*׋t:y‹|IPiT浘x'q %uD{%! &*lcV3GDe毬ObI\crIBSyҋCC3n|JD JXZ);/3ldU$mC c@S[A*1%AQSXݏBVZ39W߽!cmv19P -1qBϰ4t"k4Eʿv[?߰h v+ehPx@3ׇC1fdxKD ޷lc4\230۫!ejwt^C=T7/]<>.< C(:!({p[Z1m؀]`igI4f,'Zt!ժB8).SmջЀFm1$˅iN9^w1!/z3 s ]I6Y)Y2L,IlB>!@j h zG&{:JD(w'k 5R1RNj qڞd`aVdI{E RO! |k2!Db!WsN (ڔEcYye,QjP+;RgG@B:6-+D41ZeJat-JSNj}fTѷ!hG#졿-q<3)鈀fBH* vETtc~U[z+(&D""oz:{h[>)cI=}RTO^xUA@1JjH(aA< JC58T(هQ¸K6ɏ kJ*Iej;. < #@̣ȉDgcT613EiFsU +(2"|*ҌS\ڵ{5WBJwq=UyhrljNw6mߚ]⚗mvR7} K쁝*߻ :;1 ڨDL@N vԢ,vCzIb k7˵! KhDus`wIðёYIT"V[MӾ|_LͲM)lj/qn`eƀF5k4%\@)G"q%۔`2OUnbe-$rԇjX X V)5I|; jV}zoa^wddSpm 7 c)ɞ^d<1K!E[֧c֭!;ۀ c)°(:cpblp1iGBH̆U2//._W:Jp<[e!}3,lcY~]ёT3`6= #A@l#fj$C6%2«'Z& $)JI*1, am4datPLLZJ kZT[ fW v*ocZ3?j1t&ͲcK Iҋ5 0"hbZ>IQN xR%~"h LF*Oe8 xlxn-1mnrG̭m'6"I2Yct_֪.]; Fs\]wwUD´#{}Fs ֨aQYp5 2U !̍T1(yA ,.HX8:?`/|27+"U\lUI,,Գk.XnWX\vFy hw?kt۶%̐7ײPeKm&SM~{2%кSpr x yiچLgYFnH|…{W}~fQ/dâ ި06"My|O'@ॗ^Bg[У͛7ݻ(s7s='OKd?IZ;B퀅 ߿O3oo~9Ye"@Xe@Wʮ:a4$(#2ˊf͚={>jp[8|Tֳ?x9G m 70 UmgͣG9sN~ȑ뮻? z~mTZEvÇB}n#;V4g2XwY1  ; y|0 8lA0koi>xGi. X(i N# F߫GeBӉaF0$ A #i&*/nOfdvlPDI),%wPZ:tKN'"i}+ilc<؞jȜtm0YN:_Ał6l`bJmG覛n4e]fwAygy=}i;yx .'m({]2iL 4XpR=EWo!ޅ~`yeO?]TU'9: 5B21,QWbb,ׯk׮A mȧH 3+#>R{ Cad,^|7u pJe}nܸQnk ZQ[n]MٳaP8~"y,pfI|w%:TF?^|Ey+6p4bl]*I01tF@,pƨmxbdW_%%:h w 8ibنƕiRΓ^{}T)0ޢD։lcTD;1KA@I.Fۇ;EDj9'{}q{<~{*? 䅭bBe̝>=Ĩy =#)鐈y[@$i\DOR?arYglaZF5?@2[֯k]~>Qttɩl""3 jVׇ|B椎 1qTM d7xw]a׆sp}{@%`"%BW9r#P(.\pt饗x7oܱNX:yoCTX:-:2]I( ؔSBZ';W )-_-HF۠>%J'lf-K QjNg Mb˖-!~33X;+28X9o=a[RLkt nmYLg+p `lgi .IpGȌe裏bvY-FujA]ٲSlcmBJq9]@QlcQbή#8F@_CE2鞿,ʑ5oE z\kؚ1u}v3@M9qă>o,ojI#&d<܅cfVtsG mkx}`+ rJ aӗڱ{n~dv|\4O@"Q>WB#w$4Z% *7v=mM/\˖hYKaTe4cz6@sEǫj+<vW_ӧOۯ,9q.;B@p}@ 8 l!v&Cҡs%ߌEKa+P -PꃴN : Jk%~Hvʼn4(!{|MsBHz _nmŒWSO1.8 _$%ؠ{wַϫ0~[nGy$t"g\}1OJ#v}ov1v"TW, O{DP8t E(v} }?3BIuGhD{A5JېdqDxGp c9mȩ4eGp@)8@ 񡷪-m4eGp@($ N8pUC@xG9JW t#8E@XQlcp8厀#81ȪDTIL^pG`D )/*pGXew(s@t;#0Kw(6f9KS#r>Za6c,B3}):V2aC4U>`tuE2::#YA~k#\^`Y.p#c6ET"qy-s  r  7X1d7 ,_Vh7"DDe&z8!Wj2oh'OD?<)4~6/R&g}~z_ꫯF~uEI|jܲe @f! u"% [Y19~Qm RO?+&:uJ4K԰pDm#D~M i ( R&f&m1G[2,* Ra-N¦GJ8)1#j`Nz3cLsaIGd^''s0}K Mfc EDU١s9tP?@|Itjn&nY_MM4!F%FaڵҮ+\p3J#¿T񗗎(S&4P7%%y7w}] Pi}p1o{M75@(#ULE^pBGQ%;v-/(_{MYM=ȺkJ} { [si͇_WwF J^p,V;UR:AR>@A?Picture 1"br3n";8~ٕ}Qnѕr3n";8~PNG  IHDR sRGBzIDATx^I]ŕ0H,Җl?Bx EE‚@"EXˈfA X",D[ dA@1,YX B#0hXHcH؋?oQ[wz_ UX?#8@"Xދ;#8_#898A8#858#Լ#8_#89?B#8X?&5_N#8cA1a9#8#cyGpL?->:'2>s_?#8K@c??{G?'x緿mbw$#/ 4v@;ʠTRPs!7b|Щ_ɓ'B6p ڡcǎAge _$hBO8>[ՉЌ_zI|ꫯV_pSQPyQj!wV Vnݪ=K=h͑?Ou>uT(B MIȨԭL#ÏiWބk/)o g+?7>"G'( 15%6FI Rf.IB?Jq6IZ<,iMҚ =&?͉'iحrKϓx:xȸ8;Gp\e9/`p\jݞ2},*1lK|Xr/9#8i`yƊKixiGp `zc"d:#0>\ߜ8E# 9 jp=;#0>Dۯ79N#8#F@ǤbLCYeGp@LH1DNGpdL)K8#0rZ?|>uGL1dž 3WSD׎ۄ:=@##yq^e\}$w[4I_=n%2lڟ\=wy#=|hOmhێ/bOv+>3JM;/RVϐ-(l۸GS g ՕH5>$=8pb [Kޣ>pvU]d\U ҥ'mf8mYD:/*6=f0YOB۩G`ѽ@L"&#vp0X[u􅹀1 ^9Iɓz0_8Vcf6;]J4r%Y[WƙjWlY}.gfM@?ЌYIje!@ٵᗿ%.]^ȠР[X*7p?X a aGC=$s ̫[_ Ϯ.Kʻ붃q hF̋+uňe[ԿYY?l|n._G K\TUբ 堖|TSQ/|1E3оTZuhf7-NV,e"TL#2l=^ X֏A`r3tӥA@*Y4L`Xqȴ%VEn )N7؈Ķŧpc j_adΒ} RS5He~T@}=i ),ZVEB D֛k/D=e{F*V?B*\щ6wZx5ΣpB&?butV?$HE}*ۢTIedkG~W Ö)f M~O kvG1 /GʰWJ24;GUJ4*"ͅ0flkxЊ# =xJ r%h+ RŌ!Gp$DL ~aY/M7݄R}!1GF`,`D;7|S1~N5cyu]hGXzbM&] U:wG`$(T3aA8Rt քp!0$\|V.Tț(Pт/&q^w^pq"[dbj82"C~SjU]8;%^p&@C "v킒Rc;vab5^Cb$w2Gqo2 ~r<GVAmߦ8-2v5@ 9c<'2ȎUdEFG`8xXc (ňI~g{G.rǨpQ=xG54'p83]ݷ/桻t׾5opG@ȯ2V)k8#A ~/?DYwi\4^z)ijS]J<_z饕v0smݺ}-{:Ž#L+%p%x~Ř)*ɕ/.N󉅊+7 v-{nW>3N# @> Eo| {+x!LBlڴAh06\]FR$o|#^pBGL}Y:={S4K.$+v<|x#èѮםO.,( kSY~CS+v]^:ɇՑdVb;FW'C7+  {fyXOkUλ Gw*VcG?^oW󅗇앱;bs1c$5&+ }5V̘# hwO"PatVH(F/B&~&h ?d.3_~=[laW]uUd0- !;]<3MKc`l>@}v3%bN* ˘mkfYguw<ë0,mqc=l!R*fZ4j_5-d$"L~kP`.˄@Z-!@gGvԼE<@=ō?Ӟ)~'Ǐ-[ܹ="o.@B [J]H29+VHހg ۴(ܬ|$qc&̹*ݍ]gN*yDw TssdYO{)\Jp{thPV(d?7N=38pG=U<>^7bS?@{05ՔIbQ7-89nNNر/$ 9NT뮻$ZCc*6ߘ9 0h4&?ȏcpDů.Bq>opD6vUj$#0m6]!p{H,pHOWwI9C>!RՈ`G, $N#,vz!sdPQwygTTe/6Q* G{s30*#9ZX+DE7M%29p@F#Bh뒫G1rA#8v -?F ]RDaY,AzYʣŠ<4+~B#d   :8-ŏGnUO ©>N:*GXǘ&7XD="4 #Nu{3%ć{֭#sLa/D"?H HIMIN%-7Ċ.;d*d%啼8?c@>?I=Eg v8vX&r;Xg:I]$^J\^x-9qZa-؁|1 ] !㫄:c|aK8 5,1޻#T/4$P//< AxW 1 % e+">&N;md֭tT%8.}f 9AN "q={`¬#\ 6pF=e>ӈdrƷ?y|7C2( Wâ2Rׇ3ޯ#041 . &GAǺTP,'|Ӷ'{⯀#nU4g1QX <`tYG̗erGM#W2_#QFrO$/c/SL,' cc:6B AiYdGEi6TV{ќ5+C؁pƌjB^^|۸#~;̃~,r9. EE.oANL|1ґDaAME[*w.[سTdJ!@ݻwc "NKy'Զ,G҆E(!⥻kQeH5daC.+EXx wF&3NEx]U%E2 zQG=j۵6qd~׿B i4TC}#Eht/˰["_0UjJ{!c{/oD."nMǢ_Nh*Ȏ%ج6FOJsm]÷pI2A6~G2]4BcYG7w"61j JjI(aQhB|rCgeT8ɉL8-G.َJIaZȿ0:"ffW4^d'lB CY@,KXDžgL;:c%WwyG}rU|/?p_%]ȅKOrM%y(xChCeD3ax96" =SM7ݴcQ}/Aro7SDezta_ D)OlU.wpbgǃOhCRgڵ|j}O%gaڵ QTt&08n1O9xypOu8.qUw<"3Y%TY6 kMYLE^,࿽I$#XR"LVK(w#ħL ١M e֋j>Ũk)8gmv48śgʂU P)1LB믗rg`_ICl/5du22&P:~Jj ?6qJKFdP8P/T+%5ecY0+K`Pᵅ~W0ay538z?LMh< iII6Ez9H:J1xDEk [RL8b8(f:`{/?&=, fDlFZPbFzyZvTA|*S%]5 Wi1a4$йh]~:e$L1Uϟ(UQO}nxzzD7 SnaC]'17 rCdS%0Lq+lSlaxFw 2STڰ^]?$qǨ4#?X 2\#Y*vNd:Kl慵:6%iȭR g?.!S$U[iZ5v ov3eV֫"c,H⭌YZҒ|뢰Y+kic]nKx4R9mV t ;jVg$ҟ=0)bp3 ,olRwX6/s^וZ /81)V؆FD(G{H H|:2Z"<`DPq٠PQlٯCEy)XqNaۦkعFmƜL'V!ˡp)"7u"sP:H5K1f~e4B%l;kۗnm[c^+y0:vV9TRJ X{bW\*  g+//h(…:0qS[(SrXzZlػ3C p%\H]0(_0kT"^*tV/uҵ FJs-?1Y.f13 )O&%NFүqD]V d8Fn :D7-rtN# a*1lY,Y9OnExXUlS7"R^] >RHXF_8'aa"l" bqKD!I\@z/+IY \ Tg\a'#vHcYs&A$}C5/N(w3|=zGTd|Yzx(n@K,LD̎< D,64]6akҮj0)þUA_id?lI]9ev-TU B˳($mpˎI~ ^Z2Cs*%\X'6>!ʰ2 ym$cC:G][BF;&i%|gR~']cIP: Lmb""+lOJdX F%w%͕\CgHC  ZN dfи^EG«!~P-jygvCҖ"/saY"QQ°ҘR4flP##i#SRS*V$#&F+[q;*^q mBˆEJdYCD"1z#L*fULD"Xӝ,<0_EQO:Qd]˦0-z ^7bC:%!RHEe]0GmIyuz6jN2FU=kؿ8 " y֒ ПcFyͅIDis)]Xۚb"G,cVPӴ@[ԢߔXUtO"u/^@SػI.vi$bA8d2(́-;աJ\a8m@-NRΘU$ajXi/#F)<@fӚWHtoDrXj2{H׌Z~=ў(LjkT.!@zk񻕒. f(/,+bT.̨L;s\]1 i30wLPo63 '׭#t%xT;?̪9Θ9na'wf8chG 2`08: ٬!?-X-hډmPpbikYl1sYfo0 LA^F. XSg=ĖF{~PF0r$67HR;*"Gcn i@!"QwUdͺhz֩`#p FSUCEB(;%cT=HGa 4|4O5-`ۍCUiya7#PP{mݍ ZWo=Uf.]mѸV*l-AAB:7k41#MPzڣقڼR2m"/8p;NfVrh裏8B#<&A:ujQгaÆoە~5x*0a~~-h:eo> ~!E65?oO_;K/5Sa?awt^XK?p5k"ٳv~K/U;$ڐ*OwߝLpU-VtZ7?)Sf]KƱ:t+/x)}-0m7p>FV N\Wud!"ݰYN}~Պ쨙O )zKF0ySgV]֣ ] Pv;w̔"ʜ9F0݅A| 5R-ckNS-R9D+>[N[yo4p^3hm\)+Vćj|a€Y+`0+`LBUh{@kÂl<yYD":B@C-:f@I S#5kv IfmLRlٹ~g=@I#L ƒh(ղ|N9dkcٔN100F +t.˙;̌Lˊn)%l W-5.fv"c;ó%j~{xeKW\SJG4dV>qQb, D&Fw4H*(wy vb [U{/S}OQ45 -ʌSgDM$`| U/{tQѼqXF(1&zE*Ȟ݊(IKh޽&UT /bXX7/a6QQ6-J6m* |Q3e%EmCsXwEG*\Sk׮蔊m&#d[<=/mARe?ݵkntԃde?{{'y>rߞ]28q'0xM2<3%,Bicǎ7|s0Nh=ݻw;8n*nF~f;;GaoƇGHjHӯѼQMJ1bRTpj^vckM/ (uFEWj5P Έns,/Uuh_=9( LI)G'JڲԃwGGCVދUjHsɖp9vtcn9(x%TGiVʍx!y bA>f$#<`Ap"f ,hno[-c?DtxraCJjf| r ,^(YN2(:K)4K@0o5:bRٰf+>nvsKRS.sT}GX H<3Dꨗ1 ɳMjdQ=0M85cSƨRWoC$ pB!Y|JyCEٯ&S(QFkF MZگtW2޲`5Z4Xux+NӴ2: }+ڒ. d|xQIQ3Y{//eۻs!lʐCC鮛U{B,gf]HOڀ؝bkK-0d%?"2s=N<"=Xc&IE)x$guVd-Z`n/0(o'O"JP4*`{[ڠx≎/7xx[M'9R"6GRڀ74xU_Mk?inYJ#^'U"EI ="p{)0d1 OW:qx^k/mB Fg+# 2_)hoJ `!ز׭[8mecړe }okC NQ|0+2],S.FP"̃@e1l vPs{OO5b'I$O?}ش:\|C;!'k:Af( +S,w1Q8cd}ޅkeA@bΥ$ws{> +G[I_ * #oIaf9sxs~⇶$kI:X&hܠ-Ti%FƦk 2tqUE"f#TsS7m3Q )fDq>a (@$POLqƹEB_oI.X k;|8yU=u1[P2`a:] _v"%Ȩ2vz _i=Z-ۏlAC(~Rڒ&e o'|)4I'#fbјo:(DݴtflӲRjG^A~dX+ l5lr`mA$5:g62ؒTk\ ݝGR'Gx| yh̝^HaV]X .o&Cd…T(<|6a=s enE\ vMumt,fn#FhAbZ.QX1TY7!rr{,xcJNLC[KAlKj$}HިR/ǘfc!" #sʍ8ݯ 5N }PUab]ǠwhEU(e=Ug[O@,fuZO`o[aیP[8s^Pvnم 3CN)u,?K[1rqQ(dl`pI~+#Hh:Zuoi?Ikro)zR .,'[nGΎ֋_K68G0چfO t14X_F C6#=1=kBmd`4#ރk]&hs ?иdی XXVtTW[=-耍ɾĮ b̚ʚ=;+i^R . (adQ[b7DXM2Sڪrq5K[I+C܋~sq:Guüiv?=% 4Nzv;vťl(cj\vS-e2]J{f<7U]Q.4v]_@j%)B촦0 1bukU1{, ((eC1ԮcN;ʾT6I S3颊`彋ަv `nNhUXciDa$ZR*Nת͈ wnc rj|F®E}宣z*iko01t:ui%woVP -M0;lw:A\ ]K G]k5blSM5>f1ص(|Q#{,8_/>ӖiU?m{(ZD?eaJZxDkeD׼ἍyoxI?A V ʮ&abfyY-^11 `@,$ ^ww%  wՍ?(I*P9S+>CmE̛W\ܷO=\Вfdyk׾ PS8[ 5t$Us1vY}j|@xmVY${챲JerQ%f +T;vT_L [ꂼn3!s*-IZ[XR-ؾ9y0< 5:2p ʔ\F4dOe>H2>CÕBËOX:[8GqŨ`Xc<~5N;-H$D9n˾+f^[mmÆ mvWe*^3뇞E?e 'n39Ƒ7oތ,% %ʕ5+>q`⣞j),PP(#i R(+BvJlJCafb²_Py-~ ? ͋|3azXl5jrJT9gtOdm:>xتrAűdlUJ]X u+y \+׼[?ڣ 1*?bu~eyn@6o\1il# buԲh_裏$^co0gVʚg%܆]HU k[MWHHEhENmd_}UׯJY8ujR?L%G#i;}Ku4ET^xA,VV±MiBϹ C YrKņ-ekKS}!gJ:(?WF'O҈ +(,'̦*҆ۇE(t~+Mݳ7ppMtz81i/&A# :2BK==R`âgP}ғhfS`*kKS1L*Ϟm<nOy/J{ｗ_j/wq~9`y'99oܚGs_E~߹sgQ[]5^jWIKI^ӬHzZAxyonwϳ}p=@]ܮPbTwoۖaNZFxR2̅) {@~X9+z2꿊Q%EA4 ]>r ěw6rGEGۯ-{`w҅m(6ҎVB|Vu*utQn}k쥣]ZٯbDZTedCt*m6h-13^&],y)21Iavz(*RsN=nPK@B(2Z*`??y¥pz8qBiF2bp=҅s &bPSةS"+?"t3vb*,?s(Ng?c)sr.8kn hQm!&d  `6bc3Y3hb1Sk׮P.H@ @DL4,q5iM4s&"S&I ltcDB0G_&uq*1S >vdoaZaf.~#ŗĆu4GDk%)Azcb-TLwdcjow3'…A:f]酊& $'YR3k`f+:2S˩4Gw£akf۵E*X׬m fs-xwo5:r "L:oCh7 .Vi6Y:b: DfU$dؚ,0I`< TO%#Ȳvh+tC"SGh+i^{mdI:LI:AK^ӏdғ'ӊs'JD~Yx?jPE j…sMXv|D:vgyM]tnCH\K9c][5q*ي1[ƣTk*?U#>ǖـЎchC$e mLҵL W<˞~ihfm@'=lƍFc+5KnS{dҙGu㭋폭|hzadmCќ"/s{MW;FxyUE yjVPL `Ȼc[ ,MRf+$aFa 9BSGsZ29P_Jj'Ui,,eRH{ccҐݵ ?fCVG?萍6{z˃_KјޮHdE;|B 2y, 呔x/iL<%9GRG#wUb [j%c5Ds`N?٪A~3N۷38ʆD#lPcΞ(>*̠?UXO]GL{\] 8?橬g Js[6tG\7o"[`uy'NsNts*~'x+[u]pGU{@Df5/jmVn\m1`/?jM0Dzc4U]ZFːb("oQ镝7:UPނ#R Pck f?4G`G"J ^#/,r+ZRg}SSo馛:jߚ[; ᢋ.ꧣq<ٹ@NȾ⹨Ҷ'YtQq Uɦ %A8 }PtQQ9hyM!{UD:͜XL+eۜDkz#㖞 Ɖ.<NgئJqS_ + SY`!+NޠfǏ?gT;& =]WT(wwx;Z2̫>[ X*~rYRo!\J|:;9S!^J #4 d.,8/B (tL Hk!x""qf`?1(gd@vt!' VijU8%#f*{HtiȈOf쿺}eo-gme^HuAlǏQJ |SӞяOF :RFR-ol޼j3,5A0>;DS* Z,ĹG?ᶕ6Cš^.wEYQZ m'vGn+F"DZ,EU:#rKl釤z˧FoZ6zUeۍ2I!qgNt T)G)BvuitZ?ZZ#m {ًŸU{Vkj ˺\YF?lt]P|(4S9HK[ AbRa6UڅNK/TpiyS0entlڵB rk]KBܗjِ[8|> ,I$LXWj'y":HHY<眪6vz,:ݵj/6A&F ë0p!1/jt'%Ghm.~B'K[Jn-N %%T؄Aƒ)6Lcπ*֑dHYj'mbrfy<!WDwjIl(za"', fFer鮣Z.<9G}[ J< ?%1[G*Ǡ/]IxG@ZqN U*u62l 6ywZJ^v~wG $dw2weӯȥI?I}W`(hyvQ*uXy$D#D)27ʹimzV]vX=%[LӚ5G`tv@I%'|w>q#L{ P."|Ǐ~|fB$,#pF@{_J{.`z?XBW//@V8#dHʦCsG,$%In(8= @΋{zmɺȋI\.d>G`Y]~%TvylW\qYF_ywygÅIUpv+a';/28=#ypoi0cٮbݿÇ>gReP"3t+]W/GևLKū2?$f޽=f|:, <.D/~E}ZٷoߦM֭[)Z /$;O}*@148K.iq*TBewb1$6# |zQ;=[Dik.nӅZH/XBȾfYN4p T] O> M-Ai-%eךN#/8#Ń2\s5?ɁO^y啡}Yz<@c>M[ho UF/j$o<-[Ǐ"%!X4pg::%5˽HF?"IDxaGkSǎA00 R2㖗ݩ1mp{n wgy;f.]`< *?\_)p/4$+b3cDl8@cG(,>yXf=ù/>J]m2দԯ]Bc̦(P%EsΑ~۶m·G ߡ q`wYUhU;o%5LX\oIe""/81 ;켼0_l7op#u~/O6h٬w#N_Ch! Cݼr>~z`B4K VZyuܳ)Jcf? aZ |rG"ib#8] M>oWX$"lK$%=zl#0:$R$M@'cS=f&8$ lIh綉Lx+,!f# X:tLl٘zٻu 6\incJ.*Vk5_TR$5a:Pk3X8cF $eSiS 줸"0  7bٗPSdt Ab [E#ums/Ԣ SP =ĺQwR @O~_"fѸ/5e*/ {yGȰؕ"/Y1UZ:e„/ڬ1(R@DROZT/ʀb0I .(b+A‡ꄬ#M%_hJtғv.E3PbɏֻaS У Dq ݀(Cb/asVkdyTfџ!"sHuB>qxbi 6kv8iE5) }h_ gISu駛C1b"iJckmfA/SR8NSAGvPğ+A1:ƑNɚ 侖޵Y瞣}2ilvpÂ|#e`!kC3k\sVF2!opB A\}6~,ǘlxI <8]aEa(Y;N%]g|Qĭ+JD*h\i!TK:pfDJ"pˠ+JB?lOOɐtES_"퍑2ዾf}} @c)Agm#hWQDѭ'E%0gu1;ޟgy$r#>2XSv':4';n x#bKkjF,]=ήdi0T aHzM=s:ݩ$[a+iw"ɢ&]>®Sէ2F~cce5Ec\ P[r'f!{)@XrDmjC,Ӧ-*0BD-;gc(' e("?|L!"aTč9Ph!Y-]k+!t}.0偅=v5kh_F&t<~7+²ȑ"9`w uCHTt5f;2_+«"SAn>=u8Hr[v[G*Q^;]h3FY`ϰ,/Ϡ푝$ x !Y,=jnk'~*x\r6 ob+8HEv `RDfjl?~uzB_z$d)zʶEFǮJ51rq# _^̸<`kb9XlҲWW!?F8)&ɬ޶S#E ;S&"&.H!{;pT R(f6®i ;`C}jnc6s iH)Б:z7j8ŬI @vxgje!G^4"kUmQgQg 'Yɤ%@j"/1R]1<.o?UJUvs'V*/Re\d=7gP(T\.fO-#"(NK'Ϛ׆ ƫ6tzHjYފҖ)R w3()4ge׌ UX0s9@يuZeh_3HRF^e.ZNVN}N1+»07PmrQN&/`=,V/ %+1e;iMs JG"|0bO 5fc^>7嘘 BA%f-vع[iHcj vmsx%N: K>uU{:f(ِ%MNS1t #f2XFVFcGRV~ |^bw0-&Ҝz>^'l؞YfgwwӠ$R? ^7:7z;ixVR[eA\ %RQaݦ&1]^Զ1|WBh,! x)1wZymIvDLً7bWt=/_(N)f(}afFg=P[08UT<I,LAKH-3`u "J6/eQl)uK(*3Xx̛x^(_6?m*Q<ڒԑ`8i!<@#k!/oGҕݽ#^%G##3%^QCc畑-HxOڲ)@G2u,K:o~+ߢTs$)H*dB^"-WXϗ,@O &ls(MBxo?ϑ*Ů:ԩ* ?dMgPkpo>\e.{j+=5^z);NmBM\O>d?~\g}w!%\8h /2,9|#P1Kڜa1+#Ld6+44rԇw:uuU5`)Y)#뇻3IlU[{F2EȰp,"v_^r ?f}7.8vg9ɡ7ѣ$##nCԣ*lAT1Rsy"~0Ual(%mMYՄ &qX#d!Ae#)Hd3c+ k޻@@E-G駟^rr .mqC?|)8SO2b O>;]DA"ZbU_]v Lt:/6*~,Y;x;v`nRP7nR8Z֮]9ԯw]bGxb JMY.򌱌XfĂ+"cPLɓoNLv+֭[:G ë juZ[;en.Blz- ܚa˛Dz"=!9f(Ő|^f$`۩[ kTi5O՞-jEgq@PtS^;#%d3 @GA8kFh}GwuH d+ēήY)}v蝵JW^y%mS\𻎅RfQlB<^2D[e#I(*5QLw1-JJdF ³^ ~:dyOz>=^[S_)8fu~}0 UrQjǪ/&64dׯ'˯DPJ|8(͚= R  }*t'bF9󅦈)-eV('EaRd\n 7 y,I!QCbHt,z9SƼZmg$OnUr뭷/GǏ}h$|gwkpPL{^(sYg=zteO q3.lluny Ey% s1wdsQ" KՎW#;y@F 9$ˢiAJ~C#+df)hdGE0={]j= ^|jA b@̢3<~57yHbcɟK]ғ 2<5ii[X?RITގ%j<b$\/&F/fԶ1Uz+#meBQAЗWty(y#9\$gX6>b?Qc-%4›$|^+- ʱwO$Jeد@Gf=>+_$TpWdC:YLX0Tتhl$S+拃jJ5G6Gn1JZf"DԊ]׉F;!#v xO9n談*@`yX vaرcˏ@EdΠkYL"j˖-\xS/jpx:u:q􋲞|8d[` _;:`P{Ⱦ:1 nMޔեQ` .;I)\K[2"p @uǶJ! hYf.FL؉Ђ*ʘh<"eiܬϫ%&be,=UOe=\pu;%d[ rXVVܳ(Uv5NJCK w}ۈX2Sub2)ٙ6jFktrźV7o Ȏ)1Tfx#b]#?w1֒=Jތ E=%*H0Cn `SG^Ah(ulA(;BvL@*^tuy)Jc5Oc?^z@ [i5ڐ;hnJ4T>.N">q0WQ&򠠌fG {+_Yz]]\~Kt7M2a+ְa6 ؑX: zA%hƤf(ICM_,Vɸ {i#4ȑȘ4{zmPyxb2ptDYy`RKfZE6zݲtLC: kO7p_##a\s5&MF9|G"Jƶmjd/BRO]9 ItL|F zSA E?bJ}4?vvOmmEk+a!AUa#؈ XQysyiRJ Mbƪ[0&$tjQ/ (c3%Nkpi#) Շ.0w^(.tUh=L3CvL4cx!`VGo ^Vzz6^#Fgfhaᆋ$ Z/: 7 U(ie]2+x%PƟ0j)aݲzk=# s󨼻Pdv^֊a!"U8깑l)lقckvm2e{{=:AD)2kBZG@oSu-I~tũP=# ʸ,qktx8._&s{ŝlUoX`s\2,? HIݾ ;UW]mz2I/5fߣ~cXk;Zcz2"P֡0lf CG6*j +3yeij ;T]aFq{Tɧ{Bh,5ֹ8o9EmlH'T[|8fpD/ 0'G&!#Hy蚊^gTEsXF|A/~D^EFD@G=*閑|$ ds4,[DOKno#\L+0LW!Y ӟFFt_<[Y\-!>}jek{0!p0 ¡*ecXRƙ~ La&vQm }`+{NtR: Y ]hZ80 su%XRhP68C Sf"*es'zZ]jyx;A5cuٯ,RALX+,qFRDze P-m2:Y{^ Fڑ֛jD@OƺJx"5?؝u3y (p:» f=IqEaLnj@v~|p)Bz$EPƙ]vpN;d{.g:Adm*¢=P":,=4Hz K帀Q%P;iHX- ;7:!/ϫi&vvReS>8ɓC'+[;3qO\{lvG JKSF tfy^ 0P!K3/QPc.mtڱ[2H"m(YӜ@%&YMdq9qk_$f矹1҆mGj𛅖J`V!7$wމ&. oyB"e-zy睡%*r ˀ0$*]<fb {"`Y.Bi6 7J0:֧{)d?~y#p5p®~|.۸q#Q_5ohpL| _{-[v~`oVԢSƷ0mh7|ݠ0$, n8n[40bu8MpgxzN1aĻ')!m˖-}Qcd!ѣG׮]X L Ka{Uf7*j^۰cTgEDA;=Y2rܖlvycQY8Ǻut5,2 FK/t҃]H1Y?#uG AO>$aE ZarKQ+˟pnQe%j;T F4»X@5&xnS8M v-?M6)kP'" `kJ0syvF.Nj6|«`_bdKP+?CChd8ămVK01C0ULJXXiчW(J%eaa[q1ѩl$.׼%+`Sqq\!0dp"`UJU˽N8!QHkFg?"cLf,$^f f VX*U',؍d俊X[.e8N<3x>8 "ʎFF¡(ȮQ]9_v9 1<3|iݻIu /tEė"{7Q896l@m+,PDx)8 >8-9`u/q@X;Xܟo^_b0- ׇ:{p1,@'|Bd @tMTl#AI:,8#0"b0( =a7aK$dF3wWqV dߎ+]t &S?J}饗8s8/p~~ WZNv?&;uN##|M‡sa0\ "%CHtqx V,\)~#THw ?:uX'EyW(Oi\gpp%c#Y!9iw(xwHp2G`(^y..߸vsqCwP,tX?SMy=dEi3A@FvBɝWDִ,~SS7MG|{R'SO=σ_:CTK݊]r(qFLe\C2  IfaVWŰ]l<#ɒp2fhsS+",0 U(@l/|/Q3)ß:Рu/͛7q$PGd"3ML:8{GL6&1r?u}#(>Zچ u+?:tO/[ۉ''%B+u5 7'1I%'HHЃz!T$&2%GZ:ޯ#P\zOL@'<~7+/3Bb¶^ O+;e(pբ}$0Hy\0*ݻOE~8! *H$pP~$Dq܍#8TCRT~wG`yPHa^Y>GpDGh{_# ppƊsG K AHj ;#?Va}#GGyLEGp@%?5N#8bLx_:s#0J8f=_@{uqGX2\O?tS?#8!?:,*pG8#L_8u++zStBX" W/ЋhsÆ hJ%ۣCÉ p׀m,< 2穬^TL2 EyR F k47*35@38f dQ*ᣖ +{()TB\I1k'w5SDT_&/FVZ~G;;;_}mI}M6銳?vO6G(y睧;"kb,N8k;J=tП'7|s۟@M&#mj\__H}w,Dd?zh#G !/ Vmu?1Ԭ]֤ 3</& IM(=T&? M2$HTD3 k`W%I}1Qiֵ|'U`VG A"&Wl4PK.5!R@v+Hb5MȾmSeq6XPmWtGSlFI1gp+W\D YcHjq"efF6M=m7ޠnj(463;p)vtTu6{,Ɠ_B+b6G(W( PE)%!Ղxȑ#ǎƍ .5&̎Ȩ 9ʜ8q?޺u_$}I#.B [-2`Xv"֜t82#GppWrG`pKpG Yy%GpV+GppWrG`pKpG Yy%GpV+GppWrG`pKpG Yy%GpV+GppWrٿ/ڙ=O*IENDB`$$IfP!vh#v#v:V l0(554aPyty$$IfP!vh#v#v:V l0(554aPyty$$IfP!vh#v#v:V l0(554aPyty$$IfP!vh#v#v:V l0(554aPyty$$IfP!vh#v#v:V l0(554aPyty$$IfP!vh#v#v:V l0(554aPyty$$IfP!vh#v#v:V l0(554aPytyx666666666vvvvvvvvv666666>666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@66666OJQJ_HmH nH sH tH <`< NormalCJ_HmH sH tH DA D Default Paragraph FontVi@V 0 Table Normal :V 44 la (k ( 0No List 4 @4 Footer  !4@4 Header  !<Z@<  Plain Text CJOJQJRo"R 2-Replica5$7$8$9DH$OJQJ_HmH sH tH B@2 2- Body TextM$ 2p@ P !$`'0*-/5$7$8$9DH$a$ CJOJQJ</A< 2-Body Text CharOJQJe@R Pkg0HTML Preformatted7 2( Px 4 #\'*.25@9CJOJQJ^JP/aP Pkg0HTML Preformatted Char OJQJ^JPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭Vj\{cp/IDg6wZ0s=Dĵw %;r,qlEآyDQ"Q,=c8B,!gxMD&铁M./SAe^QשF½|SˌDإbj|E7C<bʼNpr8fnߧFrI.{1fVԅ$21(t}kJV1/ ÚQL×07#]fVIhcMZ6/Hߏ bW`Gv Ts'BCt!LQ#JxݴyJ] C:= ċ(tRQ;^e1/-/A_Y)^6(p[_&N}njzb\->;nVb*.7p]M|MMM# ud9c47=iV7̪~㦓ødfÕ 5j z'^9J{rJЃ3Ax| FU9…i3Q/B)LʾRPx)04N O'> agYeHj*kblC=hPW!alfpX OAXl:XVZbr Zy4Sw3?WӊhPxzSq]y 2( SSgggj6$^W>&B+BGBJBBBHCKCFF\G^GGGHHIIIIJJLLLLLLM M(M*MGMHMMMMMMMMMNN;N=NNNPPIQKQwRyRRR>S@SvSzSaTgTVV4YHYmgqgjjqmwmnnqqrr ss)s4ssstt{tttt*u4u-w4www"x%xGyJyyy\zdzizlz~{{{{`|c|5};}I}L}TVP_9;UWޔ-/NT-9ޝɞfh (*DF`aĢƢ ;<BKeh3?pz!+/9ۯeoñȱ%)ԴٴfiqvѹԹ59ߺ SXѻ޻߿A!&0333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333LRSSNOOQٿ2@!+3LRSSNOOQٿ2@!+3-,Sy c HV $ f2- >)U*4X4 9]@JjQQ2SlX`Xq\aPkgaRoiapxygsy#<jL{2UVE*olwjf `@@@@LNO 2@V@h@@Unknown G.[x Times New Roman5Symbol3. .[x Arial_M Janson TextTimes New Roman3.[x TimesY New YorkTimes New Roman?= .Cx Courier New9MS SerifC.,.{$ Calibri Light7..{$ CalibriA$BCambria Math"  SiFҒ둧FҪflҪfl!;ccKQ;HX  $PX42! xx@ 4 Gary Knight David Knight Oh+'0x  ( 4 @ LX`hp4 Gary Knight Normal.dotmDavid Knight70Microsoft Office Word@ @l@$)X@|M^ Ҫ ՜.+,0 hp  Jonathan Publishinglfc 4 Title  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqstuvwxyz{|}~Root Entry FR^ @Data W1Tabler-WordDocument 7SummaryInformation(DocumentSummaryInformation8MsoDataStoreNR^ R^ T1LE4KBIJXG==2NR^ R^ Item  !PropertiesUCompObj r   F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q